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ABSTRACT 
The umbilical cord is a biological tissue that is readily available and is 
usually discarded.  Previous studies suggested the use of the Human 
Umbilical Vein (HUV) as an acellular vascular grafting material.  In this study, 
we attempt to develop a tissue engineered tendon model using HUVs as 
scaffolds coupled with Mesenchymal Stem Cell (MSC) therapy and with 
mechanical stimulation. HUV sections were dissected from fresh human 
umbilical cords, decellularized, and seeded with rat MSCs.  A special 
bioreactor was designed to house and dynamically stimulate the constructs 
for periods of one and two weeks. Samples cultured without dynamic 
stimulation were used as controls.  Dynamic stimulation resulted in 8 fold 
higher proliferation rates and significantly stronger (156%) and stiffer (109%) 
constructs compared to the controls.  Microscopically, dynamically stimulated 
samples showed parallel orientation of collagen fibers and spindle-shaped cell 
nuclei mimicking the morphology of native tendons. 
When higher seeding densities, of 5 and 10 million cells/ml were 
attempted extracellular matrix of the HUV significantly degraded, constructs 
had weaker mechanical properties, and cell bodies lysed after 2 weeks of 
culture.  These results indicated that, for the current design, cells were not 
able to survive at original seeding concentrations higher than 5 million 
cells/ml.  The limiting seeding density for unstimulated samples was 
calculated based on glucose consumption rates to be 3 million cells/ml.  This 
value increases for stimulated constructs due to the enhancement of nutrients’ 
transport through convective flow.  The documented findings are limited by 
the design parameters and experimental protocols followed in this study.  
xiv 
Variation of these parameters, including HUV thickness, decellularization 
techniques, or stimulation scenarios, will significantly affect the results.  
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CHAPTER 1 
GENERAL INTRODUCTION 
Tendon injuries continue to affect a significant number of Americans 
yearly, and in many cases, prevent them from normal daily activities and work 
capabilities.  The Bureau of Labor Statistics reported 44,504 tendinosis and/or 
carpal tunnel syndrome injuries in the private industry in the year 19991.  The 
same source reported that 57,420 total workers were affected from repetitive 
motion disorders in 20032.  Those who experienced tendonitis lost, on an 
average, 11 days of work.   
Athletes are prone to Achilles tendon injuries more than the general 
public3, with more than 232,000 injuries documented in 20024.  Athletes were 
prevented from participating in sports activities for up to one month in almost 
50% of the cases, and for more than one month in another 25%.  66,000 
patients were admitted to the emergency, hospitalized, or received therapy4.  
One quarter of Achilles tendon overuse injuries reported by athletes required 
surgery.  Almost one fourth of those who underwent surgery required further 
future operations4.   
Tendons do not always heal, even with prolonged durations of rest and 
immobility.  Common treatments include, strengthening, non-steroidal anti-
inflammatory drugs, braces, and cryotherapy.  When tendon replacement is 
inevitable, autografts and allografts are the available alternatives5.  However, 
autografts are limited, require surgery in two different locations and result in 
donor site morbidity.  Allografts are more readily available than autografts but 
in a significant number of cases they illicit an acute immune response5.  Due 
to the limitations in the current tissue available for tendon replacements, there 
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is a need to engineer tendon-like tissue in-vitro that possesses comparable 
mechanical properties to the innate tissue and that would evade the immune 
response. 
In this research a tissue engineered tendon model is developed by 
mechanically stimulating Mesenchymal Stem Cells (MSCs) seeded on 
decellularized Human Umbilical Veins (HUVs).  The dissertation includes 8 
chapters.   
Chapter 1 is a general introduction that documents the aims of the 
research and summarizes the contents of the rest of the dissertation.  
Chapter 2 includes and overview about tendon structure, biological 
composition and mechanical properties.  Furthermore, tendon pathologies 
and available clinical treatments are documented.  Chapter 3 includes a 
literature review of tendon tissue engineering.  The term “functional tissue 
engineering” is defined and the different aspects of this concept are 
documented including cells, scaffolds, seeding and stimulation techniques.  
The use of bioreactors in tendon tissue engineering is explored and the 
different stimulation techniques available are included.  In Chapter 4 the HUV 
is introduced as a potential scaffold for musculoskeletal tissue engineering in 
general and tendon tissue engineering in particular.  The material properties 
of the HUV scaffold are documented including a comparison of the 
mechanical and morphometric properties among cellular, decellularized, and 
seeded HUVs.  In Chapter 5 the possibility of using the HUV as a scaffold for 
tendon tissue engineering is further investigated.  A novel design of a 
bioreactor, termed as “Mechanical Stimulator for Tissue Engineering 
applications” (MSTE), is introduced.  Constructs were stimulated in the MSTE 
3 
for 1 hour per day and cultured for periods of 1 and 2 weeks.  The effect of 
stretching on the cellular, mechanical, and morphometric properties of the 
constructs was evaluated.   
Mass transport limitation and diffusion of nutrients and growth factors 
through the wall of the HUV are explored in Chapter 6.  The permeability of 
the HUV membrane to molecules with different molecular weights is 
computed, and a limiting molecule size beyond which particles are unable to 
diffuse through the HUV is estimated.  In Chapter 7 an attempt to optimize 
the seeding density of the tissue engineered constructs is demonstrated.  
HUVs with different seeding densities are tested and a potential optimal 
seeding density is reported.  Finally, Chapter 8 includes the conclusions of 
the research project, and future recommendations. 
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CHAPTER 2 
TENDON PATHOLOGIES AND CURRENT CLINICAL TREATMENTS 
2.1. INTRODUCTION 
Most of total and partial tendon ruptures are due to occupational 
overloading and sporting activities involving lack of stretching, sudden 
exertion of force (examples include abrupt jumping or weight lifting) and 
sprinting movements6,7.  In most sports and activities, overuse injuries, termed 
as “tendinopathies”8, are the most common and challenging to diagnose and 
treat since the symptoms are often dispersed and non-specific9.  Overuse of 
tendons causes continuous damage to the tissue that eventually escalates 
into a pathology when the repetitive strain overcomes the ability of the tendon 
to repair itself9,10.  This might lead to tendinosis (tendon tissue degeneration 
without inflammatory response), tendinitis (tendon tissue degeneration with 
inflammatory response), edema, partial tears, or complete ruptures8,11.  Some 
examples include tennis elbow, swimmer’s shoulder, little league elbow, 
runner’s knee, jumper’s knee, and Achilles tendinitis9,12.   
In this chapter the biological composition and mechanical properties of 
tendons, different tendon pathologies and current available remedies are 
documented.   
2.2. TENDON STRUCTURE 
Tendons are collagenous anatomical tissues that transfer the load 
exerted on muscle into the bone13,14.  The major type of cells in tendons are 
tenocytes; stellate cells scattered and sandwiched between parallel layers of 
5 
type I collagen fibers15,16 (Figure 2.1).  Tenocytes produce all the collagen and 
ground substance that composes this tissue.   
 
Figure 2.1: Histological longitudinal section of tendons. 
Tendons are mainly composed of a tertiary hierarchal structure of 
parallel bundles of collagen fibers17 (Figure 2.2) that are responsible for the 
tissue high tensile strength18.  A collagen molecule, or tropocollagen, is 
composed of a right-handed triple helix α chains that include a glycine at 
every third position of the polypeptides and are rich in the amino acid 
proline19.  Collagen fibrils are formed with packed tropocollagen molecules 
separated by a distance of 64 nm19.  A collagen fiber is thus made up of a 
group of collagen fibrils. 
A tendon primary fiber bundle, or subfascicle, is made up of parallel 
collagen fibers, following a wavy pattern, and tenocytes aligned with their 
longitudinal axes parallel to the collagen fibers (Figure 2.1)20.  A bundle of 
subfascicles composes a secondary tendon fascicle.  Similarly, a group of 
secondary fascicles forms a tendon tertiary fascicle. Covering the collagen 
subfascicles and fascicles is a layer of dense irregular connective tissue 
6 
termed endotenon21.  The epitenon is the outermost layer of dense irregular 
connective tissue covering the whole tendon17,21.  The paratenon is a loose 
connective tissue layer wrapping around the epitenon.  The epitenon and 
paratenon could be lumped up in the term “peritendon”17.  Tendons are not 
vascularised within the collagen bundles, however, large tendons are 
nourished by vasculature passing through the endotenon and epitenon 
layers17,22,23.  Lacking an inclusive vascular network and composed of cells 
with low metabolism, tendons have poor intrinsic healing capabilities8,24.  The 
healing tendon is more likely to deposit scar tissue in the injury site leading to 
a decrease in the strength of the healing tissue25. 
 
Figure 2.2: Hierarchal Arrangement of Tendon26. 
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2.3. TENDON BIOLOGICAL COMPOSITION 
The extracellular matrix (ECM) of tendons is mainly composed of 
collagen fibers26.  Collagen type I is the most abundant and constitutes 95% 
of total tendon collagen content, 90% of the total tendon protein content17, or 
86% of the fat-free dry weight of tendons (DWT)15,27.  Collagen type III, which 
is mostly present in the endotenon and epitenon28,29, and collagen type V 
constitute most of the remaining 5% of collagen in tendons; however, minute 
amounts of collagen types II, VI, IX, X, and XI are also present26.  Elastin only 
contributes 1% to 2% DWT15,17.  It is suggested that the elastic fibers help the 
collagen fibers recover their configuration after stretching is ceased30.   
The ground substance of tendons include proteoglycans (1% - 5% 
DWT), glycosaminoglycans (GAGs) of which hyaluronic acid constitutes 6%31, 
collagen type VI27, and structural glycoproteins15,17 such as Tenascin-C26.  
Proteoglycans mainly crosslink the collagen fibers together, forming the 
tendon subfascicles and fascicles12.  The proteoglycan decorin is widely 
distributed in tendons24,27.  It provides the structural support for the collagen 
fibers18 and plays a primary role in regulating collagen fiber formation in 
vivo15.  Fibromodulin, on the other hand, is present in sparse amounts in 
tendons27.  The glycoprotein fibronectin binds collagen fibers and plays an 
important role in wound healing17 
Tendons include two characteristic zones: the extension zone and the 
pressure zone.  The extension zone of the tendon is around the myotendinous 
junction where the tendon connects the muscle31,32.  The pressure zone, on 
the other hand, is where the tendon inserts into the bone through the 
osteotendinous junction or enthesis31,32.  There is a difference in the 
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composition of the tendon between these two zones.  The pressure zone 
includes up to 5% (DWT) GAGs while the tension zone includes only 0.2% 
(DWT) GAGs33.  The major type of GAG in the pressure zone is chondroitin 
sulfate while in the tension zone it is dermatan sulfate.  Heparin sulfate is 
mainly found at the myotendinous junction31.  Microscopically, the 
osteotendinous junction is composed of four distinct regions: tendon, 
fibrocartilage, mineralized fibrocartilage, and bone24,34,35.  The stellate cells of 
the tendon zone lose their characteristic ovoid shape and become rounded 
with shorter cell processes in the fibrocartilage zone where they stop 
expressing gap junction proteins36.  This shows that cells communicate 
differently in the four distinct histological zones.  In the fibrocartilage zone cell-
cell interactions are overcome by cell/matrix and cell signaling interactions via 
growth factors and cytokines36. 
2.4. TENDON MECHANICAL PROPERTIES 
Tendons have different anatomical locations in the body and thus 
different cross sectional areas relative to the muscles they are connected to10.  
Depending on the muscle they serve, tendons are subjected to different stress 
levels and therefore their tensile strength (σ), strain at maximum stress (ε), 
and modulus of elasticity (E) vary significantly (σ: 50-105 MPa, strain, ε: 8%-
14%, and E: 1.2-1.8 GPa)15,16,32.  However, these values are much lower for 
physiologic forces (σ: 15-30 MPa, ε: 1%-4%, and; E: 1.2GPa) 37,38.  Tendons 
are subjected to different loads during different sporting activities39.  For 
instance, walking applies only 2600N of force on the Achilles tendon as 
opposed to an average force of 4200N due to running40.  Moreover, blood flow 
in the peritendinous region increases due to excercise7.   
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Tendons are characterized as being viscoelastic24,41 due to the highly 
hydrated nature of the tissue and the sliding and slipping interactions between 
collagen and the rest of the ground substance26.  Being viscoelastic, they form 
a hysteresis loop upon loading and unloading with the area under the 
hysteresis loop representing the energy released.  Stress relaxation and 
creep are the two tests that demonstrate viscoelasticity24,30.  During the stress 
relaxation test, the sample is subjected to a constant strain allowing the stress 
in the tissue to decrease with time.  While in the creep test the tendon is 
stretched with a constant force while the tissue lengthens with time41.   
Figure 2.3 shows a typical stress strain curve of tendons26.  Collagen 
fibers in tendons have a wavy morphology termed as “crimp”12,42.  This crimp 
property enables the tendon to initially elongate, straightening the collagen 
fibers, at about 2% strain43, without a significant increase in the stress 
experienced by the tissue7, thus protecting the muscle during abrupt high 
loading events12.  Due to the crimping of collagen fibers, tendons act as 
springs that store energy to be released upon exertion of force, thus 
transmitting the force from the muscle to the bone12.  Crimp property of the 
tendon is responsible for the original nonlinear or “toe” region in the stress-
strain curve, where collagen fibers stretch out and become straight loosing 
their crimp; then they reorient parallel to the direction of stretching44.  Thus, 
the range of this region, typically around 2% strain26, depends on the extent of 
waviness of the collagen fibers.  Physiologic loads cause strain values of up 
to 4%12,20,43 where the loading is totally reversible12 and the crimp is 
reproducible20.   
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Figure 2.3: Typical stress strain curve for human tendons showing the four distinct 
regions: Toe region, linear region, microscopic failure region, and macroscopic failure 
region26. 
The region in the stress-strain curve that spans between 2% and 4% 
strain is termed the linear region where the stress increases proportionally to 
the strain and the constant of proportionality is known as the modulus of 
elasticity, E12.  Region III is between 4% and 8% strain where the original 
wavy form of the fibers is not reproducible20 since the strain was directly 
applied to the aligned and straightened collagen fibers causing them to either 
slide adjacent to other fibers or stretch further and deform45.  In region III 
some of the collagen fibers rupture causing microscopic tears43 decreasing 
the effective cross sectional area of the tendon44 causing an increase in the 
stress value that the tendon is experiencing, and thus a decrease in the 
stiffness of the tissue with increased strain26.  Strain values beyond 8% will 
cause macroscopic tears leading to tendon rupture at almost 12% 
strain10,30,46,47.   
Tissue mechanical adaptation is the process by which cells sense the 
external mechanical loading they are subjected to and respond by altering 
their structure, or secretion pattern26 (Figure 2.4) leading to either tissue 
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regeneration or degeneration.  However, the mechanotransduction 
mechanisms by which tenocytes convert mechanical signals into biochemical 
signals are still unclear to date26.  Tenocytes communicate with one another 
via a three-dimensional network of cell processes and gap junctions which 
could be responsible for the ability of cells to detect external mechano-
signals36,48.  This initial detection leads eventually to the final gross response 
that affects the tendon tissue as a whole43. 
 
Figure 2.4: The biological responses of tenocytes due to mechanostimulation.  
Depending on the loading regime (duration, rate, magnitude) cells could either signal 
for tissue remodeling or degeneration43. 
Strain values that load the tendon ¼-⅓ its ultimate strength will 
potentially cause tendon rupture49,50.  However, not only high strain and 
loading regimes cause tendon pathologies, including tendinitis and tendinoses 
or total rupture.  Long term repetitive submaximal loading43 will eventually 
lead to inflammation and might provoke matrix degradation26,43, and cause 
fibrillar tears that would weaken the tissue51,52.  Moderate exercise, on the 
other hand, signals ECM deposition36,53,54, thus an increase in tendon cross 
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sectional area, which increases the stiffness of the tendon55,56.  It also causes 
an increase in the expression of proteoglycans36,54, matrix metalloproteinases 
(MMPs) for ECM remodeling7, and blood flow through the outer layers of the 
tendon7.   
2.5. SYMPTOMS IN TENDON PATHOLOGIES 
Healthy tendons have a white gleaming appearance that radiates 
under polarized light8.  Microscopically, they are composed of parallel 
continuous bundles of collagen type I and spindle shaped cells longitudinally 
sandwiched between the collagen fascicles.  Due to overuse or injury, 
tendons loose the glittering, become grayish or brownish in color8, and get 
inflamed43.  Collagen fibers undergo degeneration16 and morphological 
alterations and cells proliferate causing hypercellularity in the affected area.  
Moreover, protein expression is altered causing a change in the properties 
and morphology of the tendon tissue.  For example, tenocytes start depositing 
Type III collagen instead of Type I collagen which causes a decrease in the 
mechanical strength of the tendon57-59.   
In general, tendon pathologies could be classified into three main 
categories: tendinosis, tendinitis, and paratenonitis8,10,16.  Tendinosis is a non-
inflammatory degeneration of the ECM and fibers accompanied with a grayish 
appearance of the tissue8-10,16,22,60.  A partial rupture is always surrounded by 
a non-inflammatory lesion suggesting that partial rupture is a complication of 
tendinosis18.  Since tendinosis is a non-inflammatory pathology, steroid 
injections failed to alleviate the symptoms of this condition.  A study was 
performed on 298 patients who suffered from chronic Achilles tendinopathies.  
Most patients complained of mornings stiffness, tenderness, and pain on 
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exertion3.  In many cases steroid injections caused more advanced tendinosis 
and more frequent ruptures61.   
The pathology is termed as tendinitis when the tendon exhibits an 
inflammatory response8,43,62-64.  It was shown that as soon as one day after 
tendon injury neutrophils and macrophages accumulate at the affected site 
and elicit an inflammatory response65.  In this case non steroidal anti-
inflammatory drugs (NSAIDS), corticosteroids, and steroid injections are 
successfully used to alleviate the pain and stop the inflammation.  
Paratenonitis is associated with the inflammation of the paratendon layer 
surrounding the tendon tissue8,10,16.  
In a review about tendon pathologies it was reported that abnormal 
tendons share some common features such as degeneration of collagen 
fibers, an increase in cellularity66 leading to an increase in vasculature67 and 
mucoid ground substance, and a reduction in strength8,60,68,69.  Moreover, 
there seamed to be an increase in collagen type III production causing a 
decrease in the strength of the tissue8,11,57-59.  Degradation of collagen fibers 
in injured tendons could be due to tenocyte upregulated expression of 
MMP170.  Tendons with changes in collagen morphology and ground 
substance were accompanied by changes in tenocyte morphology.  The 
cytoplasmic area of tenocytes enlarged and their nuclei became rounded32.  In 
all cases reviewed it was evident that there was a lack of inflammation 
suggesting that these pathologies were rather tendinosis22,71.    
To investigate the causes of hypercellularity a study was conducted on 
11 patients having patellar tendinosis66.  In all cases high cell proliferation 
rates were associated with an increase in the expression of platelet-derived 
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growth factor receptor beta (PDGFRβ) compared to the healthy controls.  This 
suggests that hypercellularity is due to the upregulation in the expression of 
PDGFRβ 66 72.  Furthermore, hypercellularity in tendinosis was verified by 
analyzing the expression of proliferation cell nuclear antigen (PCNA)66.  This 
protein appears to be present only in proliferating cells66.   
2.6. CURRENT CLINICAL TREATMENTS 
Common treatments to tendinosis and tendinitis include, but are not 
limited to, rest, strengthening, non-steroidal anti-inflammatory drugs, 
corticosteroids, braces, cryotherapy, and surgery8.  Heat pads or cryotherapy 
could temporary alleviate pain associated with tendinitis.  Bracing and 
immobilization relieves the stress from the tendon and helps it heal.  However, 
prolonged immobilization causes a decrease in the strength and other 
mechanical properties of the tissue.  As a result rehabilitation and therapy is 
required after a period of immobilization, which usually leads to an additional 
inflammatory response depending on the extent of therapy.  After being 
stretched due to physiotherapy, tenocytes started secreting interleukin 6 (IL-
6), which is partly responsible for the inflammatory response73. 
Even though NSAIDS and corticosteroids have been used to treat 
tendinitis, a non-inflammatory pathology, these therapies had minimal effects 
on the symptoms8-11,18.  When preventive measurements fail, doctors attempt 
operative techniques such as excising the degenerated and abnormal parts of 
the tendon61,74.  In case of total tendon rupture, and when the defect is less 
than 2 cm75, suturing techniques provide adequate mechanical strength for 
the tissue and diminishes the gap between the tendon stumps.  However, 
tendon replacement might be a necessity for defects larger than 2 cm, or in 
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case of peripheral nerve injury.  Currently autografts, allografts, xenografts, 
and prosthetic devices are being used in tendon replacement surgeries24,76.  
The primary source of autografts is the hamstring77,78.  Other options are the 
flexor digitorum longus79, flexor hallucis longus79 and semitendinous 
tendons80.  Donor site morbidity and inflicted pain are the two major problems 
in autografts.  On the other hand, most individuals using allografts and 
xenografts develop an immune response81.  Synthetic grafts, such as carbon 
fibers82-84, polyester fibers84, polypropylene mesh85, and dacron86,87 result in 
decreased mechanical properties of the healing tissue88 and moreover their 
integrity is compromised with increased usage89, which leads in many cases 
to reruptures90.   
Due to the limitation in the current available treatments for tendon 
pathologies and injuries researchers started exploring other alternatives.  
Tissue engineering provides several choices for tendon replacements and 
thus a functional solution for the common and recurring problem of tendon 
pathologies. 
2.7. CONCLUSIONS 
Tendons are mainly composed of type I collagen bundles which are 
responsible for the tissue high tensile strength properties permitting it to act as 
a bridge transmitting the load exerted on muscles into bone.  Most tendon 
injuries result in the degeneration and morphological alteration of collagen 
fibers.  The exact causes of collagen degeneration are still not very well 
understood.  In general, tendon pathologies are a result of overuse rather 
than trauma.  Since tenocytes have low metabolic activity tendon healing, 
when possible, requires prolonged durations of rest and immobility.  Current 
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surgical techniques to fix tendon ruptures have several limitations including 
decreased mechanical properties of the healed tissue, limited availability of 
autografts, high potential for inflammation and disease transmission from 
allografts and xenografts, and short functional lifetime of prosthetic devices.   
Lacking a satisfactory clinical treatment for tendon pathologies 
research has been directed toward exploring alternative approaches.  Tissue 
engineering provides several functional choices for tendon replacements. The 
different aspects of tendon tissue engineering are further discussed in 
Chapter 3. 
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CHAPTER 3 
TENDON TISSUE ENGINEERING:  LITERATURE REVIEW 
3.1. INTRODUCTION 
Tendons malfunction either due to a natural injury, trauma, or a 
disorder.  In all cases natural regeneration needs to be enhanced by 
medication and, in many instances, by surgery.  Surgical techniques are 
limited to suturing, autografts, allografts, xenografts, and prosthetics24,76.  
Tendon tissue engineering stems from the challenge presented by the limited 
resources for natural implants and the ineffectiveness of previous curing 
approaches.  Since the native tendon tissue is subjected to stretching during 
physiological activities, and since Immobilization significantly lowers its 
ultimate strength30,52,53,91, it is desirable to incorporate mechanical stimulation 
techniques in tissue engineered tendon models in an effort to mimic the in 
vivo environment.  The challenge in tissue engineering resides in the design 
of a functional bioreactor that would: (1) house the engineered construct 
under sterile conditions; and (2) provide the appropriate stimuli that would 
result in a neo tissue with biochemical and biomechanical properties 
comparable to the in situ tissue.  The various aspects of tendon tissue 
engineering and recent developments in that field are presented in this 
chapter. 
3.2. FUNCTIONAL TISSUE ENGINEERING 
Tissue engineering uses the principles of engineering, biology, and 
chemistry in designing a neo tissue that would augment a malfunctioning in 
vivo tissue92.  Since the traditional methods of treating tendon injuries and 
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disorders are not completely effective and have several limitations, tissue 
engineering has gained remarkable support as an approach to treat tendon 
disorders circumventing the limitations of existing therapies19,93. 
The main requirements for a functional engineered tissue include 
reparative cellular components that proliferate on a biocompatible scaffold 
grown within a bioreactor which provides specific biochemical and 
biomechanical signals to regulate cell differentiation and tissue   
assembly89,93-95. Further explanation and elaboration on the different 
components of functional tissue engineering for tendon applications are 
included herein. 
3.2.1. Cells 
Cells are by far the most important component of an engineered tissue.  
They are the living component of the construct.  Given the suitable 
environment cells would start secreting matrix that would eventually form the 
neotissue.  The type and properties of secreted matrix depend on the different 
stimuli that cells are subjected to.  For tendon tissue engineering fibroblasts 
and tenocytes have been commonly employed96-98.  It is imperative that cells 
used in the tissue construct have the ability to proliferate and deposit matrix at 
a high rate in order to be able to implant the neo tissue in the patient soon 
after the injury.  Primary tenocytes are almost mature and do not proliferate at 
a high rate99.  Another type of cells that is abundant and has been widely 
exploited to treat tendon defects in-vivo100-103 and in tendon tissue engineering 
in-vitro 102,104,105 is Mesenchymal Stem Cells (MSCs). 
MSCs are undifferentiated pluripotent cells that have the potential to 
differentiate into a number of mature cells of different lineages, depending on 
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the biochemical and biophysical stimuli that they are subjected to106-108.  
These lineages include, but not limited to, osteoblasts (bone)109-114, 
chrondocytes (cartilage)111-114, hepatocytes (liver)115, adipocytes (fat)112,113,115, 
glial cells (neural tissue)112,116,117, and fibroblasts (tendon and 
ligament)94,114,118,119.  The most popular source of MSCs is the bone marrow, 
however, pluripotent stem cells have also been extracted from other 
anatomical locations such as the subcutaneous adipose tissue120, and the 
Wharton’s Jelly105.  Although the number of MSCs decline dramatically with 
age, their ability to differentiate and repair tissue is retained96.  Being 
intermediate between embryonic and adult tissue MSCs may provide an in 
situ source of healing cells throughout an adult’s lifetime121. 
MSCs were found to undergo cell fusion in the case of tissue damage, 
rescuing dying cells by supplying extracellular matrix (ECM) and organellar 
components115.  They provide a beneficial environment for damaged tissue by 
secreting cytokines and trophic factors115.  However, fetal bovine serum (FBS) 
is a requirement for the culture of MSCs.  As a result, MSCs cultured and 
expanded in FBS might elicit an immune response in some individuals.  To 
evade the immune response MSCs could be cultured for two days in the 
serum of the host, prior to being injected. 
3.2.2. Scaffolds 
Cells are greatly affected by the surface to which they adhere.  The 
type and properties of the scaffold used for seeding could alter the 
proliferation rate and ECM deposited by cells, and thus affect the final 
biomechanical and morphological properties of the engineered tissue93.  The 
primary objective of using a scaffold is to provide mechanical stability and 
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integrity to the construct and to supply a template for three-dimensional 
organization of the developing tissue93.  The final goal is to obtain de novo 
tissue with biomechanical properties comparable to the damaged tissue.   
The scaffold used for tissue engineering must be non-toxic and 
biocompatible, i.e. evades the immune response.  Biocompatible scaffolds 
could be either polymeric (non-biodegradable or biodegradable) or biological.  
However, a second surgery might be necessary to remove the implanted non-
biodegradable scaffold after the tissue heals. If using a biodegradable 
polymer it is imperative that (1) the degradation products be biocompatible as 
well, and (2) the degradation rate of the scaffold be comparable to the tissue 
repair rate so that the implanted construct does not loose its mechanical 
integrity76,89. 
3.2.2.1. Polymeric Scaffolds 
Non-biodegradable scaffolds include carbon fibers82-84, polyester 
fibers84, polypropylene mesh85, and dacron86,87.  As mentioned in chapter 2, 
these scaffolds result in decreased mechanical properties of the healing 
tissue88 and they have a limited operative duration89. 
Biodegradable scaffolds include synthetic poly α-hydroxy ester (PHE) 
polymers such as polylactic acid (PLA)122, polyglycolic acid (PGA) and its co-
polymer with PLA (PLGA)75,77, poly L-lactic acid (PLLA)123, polycaprolactone 
(PCL)122, poly N-acetyl-D-glucosamine (chitin)122, polydioxanone124, and 
composites like chitin/PCL122,125.  Extensive research is being conducted on 
the regeneration of in vivo tissue using PHE.  Since PLGA and its degradation 
products are non-toxic and biocompatible, and since its degradation rate can 
be tuned to follow the rate of formation of human tissue125, this material has 
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gained the approval of the U.S. Food and Drug Administration for degradable 
sutures and it is currently investigated for a variety of human clinical 
applications126.  
Polymeric scaffolds have adequate initial tensile strength to act as 
tendon replacements; however they do not always evade the immune 
response, and once degraded the strength of the resulting construct 
decreases significantly.  In general PLLA scaffolds have been shown to be a 
better scaffold for tendon and ligament tissue reconstruction than PGA97,123.   
Tenocytes were harvested from deep flexor tendons of hen feet and 
seeded (20x106 cells/ml) on PGA unwoven fibers75.  The constructs were 
stretched continuously and were compared to the un-stretched controls.  Six 
weeks post-seeding experimental samples showed parallel alignment of type I 
collagen with tensile strength values three folds higher than the controls.  The 
authors extended their investigation to an in-vivo model in which they 
wrapped their PGA seeded constructs with intestinal submucosa and cultured 
them in-vitro for a week prior to transplanting them in hens flexor tendons 
defects 77.  Eight weeks post surgery the defect was bridged by a collagenous 
tube like structure with randomly shaped fibers and abundance of tenocytes.  
The PGA fibers in the defect area were not degraded and surrounded by 
inflammatory cells.  Moreover, the tensile strength of the construct was similar 
to that of the biomaterial without cells reflecting that after 8 weeks of culturing 
in-vivo the remodeling action of cells did not account for any additional 
mechanical strength or tendon-like morphogenesis. 
When implanted in vivo replacing Achilles tendon defects of Japanese 
white rabbits PLA and chitin/PCL scaffolds allowed deposition of collagen type 
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I and III, however, there was a significant decrease in the ultimate strength of 
the constructs 26 weeks after surgery for all tested materials122. 
Given the problems faced when using polymeric scaffolds, such as: the 
rate of degradation of the material, immune response development, and 
inferior mechanical properties; another source of scaffolding material was 
necessary.  Biological scaffolds represent an alternative potential source for 
tissue engineering.   
3.2.2.2. Biological Scaffolds 
The use of natural acellular biomaterials as scaffolds for tissue 
engineering is very desirable since these materials, when processed properly, 
elude the immune response.  Collagen gel is used extensively as scaffolding 
material for tendon and ligament applications13,98,127,128.  However, constructs 
engineered with seeded collagen gels had inferior mechanical strength (<0.15 
MPa after 2 weeks of seeding13,128,129) compared to human tendons (60-125 
MPa130).  Other recent options for biological scaffolds are small intestinal 
submucosa131,132, collagen fibers133, and Human Umbilical Veins (HUVs)134.  
The advantage of using these materials is that they have initial ultimate stress 
and stiffness values significantly higher than collagen gels.   
3.2.2.3. The Human Umbilical Vein 
The HUV is one of three vessels present in the human umbilical cord 
(Figure 3.1).  It possesses longitudinal stiffness comparable to human 
tendons and ligaments (> 10 MPa79) and a tensile strength (1.56±1.04 MPa79) 
ten folds higher than seeded collagen gels.  However, the non uniform 
thickness of the vein due to the manual dissection of the cord resulted in 
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significant variation in its mechanical properties79,134.  A novel automated 
dissection technique has proven to render cords with more uniform thickness 
and surface morphology resulting in less variable mechanical properties134.   
 
Figure 3.1: Histologic cross section of the umbilical cord135. 
The Wharton’s jelly constitutes the embryonic connective tissue of the 
umbilical cord that surrounds the blood vessels136 and protects them from 
external mechanical forces137.  The HUV matrix is primarily composed of 
collagen and is rich in GAGs, mostly hyaluronic acid (70% of total GAG 
content)138,139, and the proteoglycan decorin138.  It is affluent with different 
growth factors including insulin-like growth factor140, fibroblast growth 
factor136, transforming growth factor beta136,141, platelet-derived growth 
factor136 and epidermal growth factor136,141.  With such a composition 
abundant with growth factors, GAGs and proteoglycans, the HUV probably 
provides an environment that supports cell proliferation and ECM deposition.  
3.2.3. Seeding Techniques 
A large number of cells is required on the scaffold to achieve 
successful ECM deposition in vitro142,143.  The final construct cellularity has 
been found to be relatively independent of the cell seeding number; however, 
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ECM components deposited were optimized with increased cell seeding 
density144,145.  Moreover, uniform cell seeding is required to obtain 
homogeneous tissue formation throughout the scaffold especially in the 
central part92.  Thus, optimizing seeding density and homogenizing seeding 
techniques are two critical components of functional tissue engineering. 
3.2.4. Stimulation Techniques 
Cells within a construct respond and adapt to the chemical and 
mechanical stimuli to which they are exposed in vivo93.  To achieve efficient 
cell proliferation, proper differentiation and sufficient matrix deposition it is 
necessary to replicate the actual tissue environment.  There are mainly two 
types of stimulation techniques: chemical and mechanical. 
Chemical stimulation involves the addition of growth factors to the 
culture media.  Growth factors are polypeptides that support various terminal 
phenotypes and stimulate cell proliferation19,93.  Some of the most commonly 
used growth factors are transforming growth factors-β (TGF-β) which regulate 
stem cell recruitment and differentiation146-148;  bone morphogenetic proteins 
(BMP) induce in vivo osteogenesis146,149-151; and fibroblast growth factors 
(FGF) are known to support angiogenesis especially in tendon and ligament 
tissue104,147,152.  
In vivo, cells and tissues are continuously subjected to mechanical 
stimuli that affect the tissue’s developing morphology153 and its biomechanical 
properties154.  Thus it is important to replicate these loading regimes in vitro 
when attempting to develop a neotissue.  As such, most of researchers 
incorporated stretching techniques in their bioreactor designs for tendon 
tissue engineering94,98,129,155-158.  
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3.3. BIOREACTORS IN TISSUE ENGINEERING 
A bioreactor is a device that provides a controlled sterile environment 
for the development of engineered tissue92.  It confines the cultured cells 
within barriers that mimic the physiological conditions and provide mechanical 
stimulation to enhance mass transfer and nutrient transport within the seeded 
cells89.  The dynamic environment within bioreactors has been shown to affect 
the phenotype of differentiated MSCs, the deposition of ECM components, 
and the growth and development of tissue92.   
There are several approaches for designing bioreactors for tendon 
tissue engineering.  One possibility is to implant a conductive scaffold in the 
injury or diseased site that would give the tissue mechanical integrity prior to 
rejuvenation (in vivo bioreactor).  Another approach is to seed the scaffold 
with autologous cells in vitro and then implant it into the defect site.  A third 
approach is to engineer the whole tissue or organ in vitro, using a 
biocompatible scaffold, and only implant it in the patient when the 
morphological, biological and biomechanical properties of the engineered 
construct match those of the natural tissue (in vitro bioreactor).   
Currently several designs of bioreactors are employed for different 
types of tissue culture.  The different existing bioreactors for culturing tendon 
tissue are included henceforth. 
3.3.1. Static Cultures 
Static cell culture has been widely used in the past.  The cells are 
deposited on a scaffold, supplied with the appropriate growth media, and 
cultured in an incubator.  However, numerous studies have shown that static 
cultures result in a non-homogeneous cell distribution159.  Moreover, transport 
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of nutrients into large scaffolds have been proven to be problematic142 and 
consequently cells may grow preferentially at the periphery of the 
scaffold160,161.  In this case ECM components would be deposited only on the 
external surface giving the engineered construct non-uniform morphological 
and biomechanical properties.  The presence or absence of mechanical 
stimulation primarily affects the final ECM deposited in the engineered 
constructs114,128,173. 
Tendon tissue in vivo is subjected to mechanical stimulation, and thus 
static cultures cannot mimic the physiological environment and will not be 
capable of replicating the in vivo tissue.  As such, it is imperative to apply a 
mechanical force during the culturing process to produce a phenotypically 
proper tissue159,162,163.  Static cultures currently serve as controls to evaluate 
bioengineered tissue. 
3.3.2. Autologous Cell Transplants 
Autologous cell transplantation includes harvesting functional cells from 
the patient, proliferating them in vitro, and implanting the expanded cell 
culture in the defective or injured segment of the tissue.  The transplanted 
cells secrete healthy natural ECM that would augment the deficiency in the 
tissue. 
In a number of studies autologous MSCs were implanted in rabbit 
tendon defects100,102,103.  In all cases engineered tendons demonstrated 
significantly higher mechanical properties than naturally healing tendons, but 
inadequate strength and stiffness compared to natural tendons.  Moreover, 
ectopic bone formation was noted in one study102.  In another study MSCs in 
the treated tendon remained round and collagen fibers did not align in a 
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parallel direction, possibly indicating that transplantation of MSCs without any 
chemical or mechanical stimulation did not affect the microstructure of the 
tendon103.   
3.3.3. In Vivo Bioreactors 
The approach of in vivo bioreactors depends on the conductive 
properties of the implanted scaffold to recruit tenocytes and MSCs from the 
neighboring tissue.  This approach takes advantage of the physiological 
environment to supply the necessary growth factors and nutrients to the 
construct.  The main challenge is to find the appropriate scaffolding material 
that would induce the infiltration of cells and the differentiation of MSCs into 
an adequate lineage.   
A polymeric fiber scaffold made of polylactide-co-glycolide was 
designed to serve as an in vivo bioreactor for tendon and ligament tissue 
regeneration97.  The mechanical and morphometric properties of the scaffold 
were optimized in vitro to match those of the native tissue.  However, no data 
was reported on the behavior of the scaffold once implanted in vivo.   
Another example of a tendon in vivo bioreactor is a biological scaffold 
prepared by decellularizing the flexor digitorum profundus (FDP) tendon164.  
After decellularization and optimized modifications, the FDP had an increased 
porosity to allow cellular migration through the scaffold.  It was reported that 
the novel design of the FDP scaffold proved to be cytocompatible in vitro and 
allowed tenocytes’ infiltration in vivo without showing any significant immune 
rejection.  Moreover, the scaffold retained almost 78% of the strength and 
stiffness of the native tissue prior to implantation. 
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3.3.4. In-Vitro Bioreactors 
Several designs of bioreactors have been implemented to mechanically 
stimulate tissue constructs in-vitro 94,98,129,155-158.  All of the designed models 
use a motor to apply cyclic loading to the constructs under sterile conditions.  
The constructs are placed in a closed environment, fixed at one end and 
attached at the other end to an actuator that applies cyclic loading (Figure 
3.2).   
 
Figure 3.2: Simple design of a cyclic traction device5. 
The number of constructs that could be stimulated simultaneously 
using a single motor ranged from a single construct5 to up to six constructs157.  
In some designs the actuator is controlled by a computer129,157 for accurate 
application of loads, and the applied loading and resulting extension are 
monitored by a load cell and linear variable differential transformer (LVDT), 
respectively156,157.   
3.4. CHEMICAL STIMULATION IN TENDON TISSUE ENGINEERING 
Most of the growth factors studied in tendon tissue regeneration lead to 
an increase in matrix synthesis.  For instance, platelet derived growth factor 
(PDGF)165, insuline-like growth factor (IGF)165,166, epidermal growth factor 
(EGF)165, and fibroblast growth factor (FGF) 167 all increased cell proliferation 
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and matrix synthesis.  Growth and differentiation factors 5 and 6 increased 
tensile strength of tendons168, and induced neotendon formation169. 
Limited research has been conducted on the effect of growth factors on 
the differentiation of MSCs into a tendon lineage.  The addition of fibroblast 
growth factor 2 in low doses (3 ng/ml) appears to increase the proliferation 
rate of MSCs and enhance the mRNA expression of some tendon markers 
(collagen types I and III and fibronectin)104.   
Most of the Bone Morphogenetic Protein (BMP) family directs MSCs 
into osteoblastic lineage, however, it has been reported that BMP12 rather 
directs these cells towards a tendon lineage170.  In addition, this growth factor 
may play a role in early phases of tendon tissue regeneration171.  Figure 3.3 
shows the signaling pathway of BMP.  BMPs are members of the transforming 
growth factor β (TGF-β) family which have a unique two-type serine/threonine 
kinase cell surface receptor.  The initial binding of the BMP domains to the 
kinase receptors activates the signaling cascade172.  Originally, type II 
receptor kinase phosphorylates the type I receptor, which in turn 
phosphorylates the signaling molecules Smads 1, 5, and 8.  Upon 
phosphorylation, these cytoplasmic molecules bind to Smad4 and translocate 
into the cell nucleus activating the transcriptional factors for the early BMP 
response genes172. 
Bone Marrow MSCs transfected with BMP12 seem to differentiate into 
tenocytes170,173.  The transfected cells became slimmer with thinner processes 
and more organelles than MSCs.  Moreover, the transfected cells showed an 
increase in the production of type I collagen173,174 and they were positive for 
CD44 and negative for HLA-DR suggesting that they are not fibroblastic.  
30 
Growth and differentiation factor 7 (GDF7), the homologous of human BMP-
12 in mice, induced mice neotendon formation174.  MSCs could be further 
directed toward a tendon lineage through the effect of the signaling molecule 
Smad8118.  When MSCs were transfected with the active biological form of 
Smad8 (Smad8 L+MH2), the cells started to exhibit tenocyte morphological 
characteristics and gene expression118. 
 
Figure 3.3: Signaling Mechanism for BMPs175. 
3.5. MECHANICAL STIMULATION IN TENDON TISSUE ENGINEERING 
Tenocytes have been widely found to respond to mechanical 
stimuli24,62.  This is only logical since tenocytes undergo mechanical stretching 
in their in vivo environment due to normal daily activities.  Being in close 
proximity in the longitudinal direction, and connected by gap junction176, these 
cells need to communicate to grow48.  As a result, tendons need to protect 
their gap junctions when they undergo mechanical stretching176.  It has been 
shown that tenocytes contained actin stress fibers that spread along their 
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longitudinal axes and intersect fibers from other tenocytes through adherens 
junctions176.  It seams that when subjected to mechanical loading tenocytes 
protect their gap junctions by adhering more strongly together via their stress 
fibers.  It is suggested that these contractile stress fibers may provide a 
dynamic stress recovering mechanism176. 
Immobilization lowers the ultimate strength of tendons 
eminently30,52,53,91, whereas moderate exercise increases the stiffness and 
strength of the tendon55,56.  Moreover, mechanostimulation increases the 
secretion pattern of important growth factors in tendons such as: TGF-β, basic 
FGF; and PDGF147.  This reveals that stretching may have a positive influence 
on tendon healing147.  As a result, tissue engineers incorporated cyclic and 
continuous stretching in their soft tissue replacement designs13,94,98,155. 
Mechanical stimulation of collagenous constructs seeded with MSCs 
increased the expression of ligament and tendon markers, namely collagens 
type I and type III94, fibronectin94, and tenascin-C94,177.  These results indicate 
that MSCs could differentiate into tenocytes under the sole action of 
mechanical stimulation.  However, poor mechanical properties of cultured 
collagen gel constructs prevent their use in-vivo for tendon replacement178. 
Upon the application of longitudinal force to tissue constructs, cells 
aligned in the direction of stretching158,179,180 giving the construct a tendon-like 
appearance13.  Two-dimensional tissue sheets deposited by human 
fibroblasts were subjected to static continuous mechanical loading158.  
Stretching induced cell and ECM alignment and increased the tensile strength 
and modulus of the tissue.  Rat knee patellar tendons were transplanted into 
the subcutaneous tissue where they were cyclically stretched for 4 weeks.  
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Stimulated tendons were significantly stronger than non-stimulated constructs 
and possessed comparable strength to the natural tendon181.  Human patellar 
tendon fibroblasts were cultured on silicone dishes and were cyclically 
stretched for different durations98.  Stretching for 15 or 60 minutes/day 
resulted in an increase in DNA and collagen syntheses.  Similar results were 
documented when embryonic tendons were subjected to cyclic loading182.   
It is important to mention that although mechanical stimulation affected 
the ultimate properties of the constructs, the form of load applied played an 
important factor.  In a study comparing the effect of static183 and cyclic 
stress156 on the biomechanical properties of collagen fascicles it was reported 
that tensile strength and elastic modulus of cultured collagen fascicles 
strongly depended on the form and magnitude of stress applied.  The study 
concluded that cyclic stresses work more effectively than static stresses in the 
biological system.   
3.6. CONCLUSIONS 
Tissue engineering provides a functional solution for the limited 
resources of natural implants and the ineffectiveness of present curing 
techniques for tendon diseases and injuries.  The challenge of this approach 
resides in the design of a functional bioreactor that would provide the 
appropriate stimuli to the seeded biocompatible scaffold, under sterile 
conditions, resulting in a construct with biomechanical properties comparable 
to native tendons. 
Several designs for bioreactors have been employed to engineer 
constructs capable of replacing the injured tendon, but the most effective ones 
incorporated mechanical stimulation in their designs.  Using functional tissue 
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engineering concepts researchers were successful in engineering tissue with 
cellular density and morphology that closely resembled tendons.  However, 
the mechanical properties of the neotissue were inferior to that of the in vivo 
tissue.  As a result, there is a need to further explore the effects of 
biochemical and biomechanical stimulations on the microenvironment of cells 
and create innovative techniques to optimize the mechanical properties of 
engineered tissue. 
A novel biological scaffold for musculoskeletal tissue engineering in 
general, and tendon tissue engineering in particular is introduced in Chapter 
4. 
34 
CHAPTER 4 
THE HUMAN UMBILICAL VEIN AS A POTENTIAL SCAFFOLD FOR 
MUSCULOSKELETAL SOFT TISSUE REGENERATION 
The contents of this chapter were published in the Journal of Artificial 
Organs, volume 32, issue 9, pp. 735-741, 2008. 
4.1. INTRODUCTION 
Musculoskeletal soft tissues that include tendons and ligaments, 
possess high tensile strength values compared to other tissues, but have poor 
intrinsic healing capabilities8.  Current remedies to musculoskeletal 
pathologies and injuries include autografts, allografts, xenografts, and 
prosthetic implants89,184.  Donor site morbidity and inflicted pain are the major 
two problems in autografts, whereas patients with allografts and xenografts 
often develop an immune response to the implanted tissue.  Prosthetic 
devices are a short term solution as their performance declines with time89.  
Lacking a satisfactory clinical treatment for tendon and ligament pathologies 
research has been directed toward alternative approaches such as tissue 
engineering24.  The first component of functional tissue engineering is the 
scaffold.  Previous studies proposed using decellularized allogenic tissue as 
scaffolds for tissue engineered constructs185-187.  When decellularized 
adequately biological tissues have several advantages over polymeric 
scaffolds, since they usually retain their biocompatibility, may evade the 
immune response, and once seeded with viable cells have the ability to self-
repair and grow187.  Several scaffolds were used in an attempt to engineer 
tendon and ligament models in-vitro.  The most common are collagen 
hydrogels13,128,129.  However, such scaffolds resulted in constructs having 
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inferior mechanical strength (<0.15 MPa after 2 weeks of seeding13,128,129) 
compared to human tendons and ligaments (13-125 MPa130,188).   
The human umbilical cord is a widely available tissue, easily procured 
directly after delivery.  Even though cord blood cells and cord matrix 
(Wharton’s jelly) cells were classified as stem cells with regenerative 
potential105, the majority of umbilical cords are still discarded.  The Wharton’s 
jelly that surrounds the Human Umbilical Vein (HUV) is rich with growth 
factors , glycosaminoglycans , and proteoglycans136,138.  With such a 
composition, the HUV provides a biocompatible environment that potentially 
supports cell proliferation and tissue regeneration.   
Recent studies were targeted towards the use of the HUV as a 
vascular graft134,189.  Hoenicka et al.189 suggested cryopreserving the HUV for 
possible future vascular autograft.  Daniel and McFetridge134 decellularized 
the HUV suggesting its use as an allograft or as a tissue engineered blood 
vessel.  In this study, the concept of using the HUV as a biological scaffold is 
expanded to include other tissues by taking advantage of the HUV’s axial 
mechanical properties.  The HUV possesses longitudinal stiffness comparable 
to human tendons and ligaments (>10 MPa)79, and a tensile strength 
(1.56±1.04 MPa)79, ten fold higher than seeded collagen gels130,188.  The main 
goal of this study was to investigate the HUV seeded with bone marrow 
Mesenchymal Stem Cells (MSCs) as a scaffold for ligament and tendon tissue 
regeneration.  To explore this possibility it is necessary that the HUV 
promotes cell integration and proliferation and provides initial mechanical 
stability to the engineered construct.  Moreover, after 2 weeks of culture the 
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seeded construct should possess significantly higher mechanical properties 
than the initial scaffold. 
4.2. MATERIALS AND METHODS 
4.2.1. Procurement and Dissection of the Human Umbilical Vein 
Fresh human umbilical cords from full term placentas were collected 
from the Women’s Delivery Center at the Norman Regional Hospital, Norman, 
OK.  Cords were stored at 4°C and processed for use no more than 72 hours 
after delivery.  The HUV was automatically dissected as described by Daniel 
and McFetridge134 .  Briefly, the umbilical cord was thoroughly washed with 
distilled water (Figure 4.1) and cut into 8.5 cm long sections.   
 
Figure 4.1: (a) Washing the human umbilical cord with distilled water. (b) A close up 
showing the insertion of a fine tip nozzle through the HUV. 
Stainless steel mandrels (McMaster-Car, Altlanta, GA) were inserted 
into the umbilical vein of each section which was secured in place by zip ties 
on both ends (Figure 4.2-a).  The sections were placed in a Styrofoam 
container, sealed, and gradually frozen to -80°C at the rate of 2.5°C/min190,191.  
A lathe (Central Machinery, Mod 33647, China) (Figure 4.2-b) was used to 
dissect the HUV from the umbilical cord resulting in an 8.5 cm long tubular 
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construct with a uniform wall thickness of 0.75 mm (Figure 4.2-c).  The outer 
diameter of the HUV was measured, using digital calipers, to be 6.7 ± 0.3 mm.   
 
Figure 4.2: (a) 8.5 cm section of umbilical cord before processing.  (b) Lathe used to 
dissect the HUV out of the umbilical cor.  (c) HUV after automatic dissection.  (d) 
invention of the HUV such that the Wharton’s Jelly matrix is on the inside. 
4.2.2. Decellularization and Storage of HUVs 
HUV sections were thawed in phosphate buffered saline (Atlanta 
Biological, Lawrenceville, GA)  at room temperature for 1 hour and then 
inverted such that the Wharton’s jelly matrix was on the inside of the scaffold 
(Figure 4.2-d).  One centimeter was discarded from each end of the HUV 
sections where the zip ties had compressed the walls of the matrix (Figure 
4.2-c).  Sections were decellularized in 1% weight/volume solution of Sodium 
Dodecyl Sulfate (Baker, Phillipsburg, NJ) on an orbital shaker at 100 rpm for 
24 hours, then thoroughly rinsed in fresh batches of distilled water for 4 
consecutive durations (10 minutes, 20 minutes, 30 minutes, and 24 hours) to 
extract the Sodium Dodecyl Sulfate (SDS) from the tissue.  Cords were then 
immersed in 75% ethanol solution to remove residual surfactant134, alleviate 
lipid eduction185.  Three consecutive washes in water followed the ethanol 
treatment.  Cords were then sterilized in a solution of 0.2% peracetic acid 
38 
(Sigma Aldrich, St. Louis, MO) for 2 hours, and washed four times in sterile 
distilled water.  Sections were finally washed in sterile phosphate buffered 
saline for 24 hours to stabilize the pH of the HUVs at physiological levels (7.2-
7.4).  HUVs were stored for a maximum duration of one week at 4°C before 
use. 
4.2.3. Extraction of MSCs  
Bone marrow stromal cells were harvested from the femur and tibia of 
6-8 week old male Wistar® rats weighing between 150 g and 200 g (Harlan, 
Indianapolis, IN) using standard procedures192,193.  Briefly, bone marrow 
aspirates were suspended in alpha minimum essential medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% fetal bovine serum (Atlanta 
Biologicals, Lawrenceville, GA), 1,000 Units/ml penicillin G (Invitrogen), 1 
mg/ml streptomycin sulfate (Invitrogen), and 2.5 µg/ml amphotericin B 
(Invitrogen).  Four sterile syringes were each filled with 5ml of standard media 
(alpha minimum essential medium supplemented with 10% fetal bovine 
serum, 100 Units /ml penicillin G, 100 µg/ml streptomycin sulfate, and 0.25 
µg/ml amphotericin B).  The bone marrow was flushed out of four bone 
aspirates into a 50ml falcon tube using the sterile syringes.  Large 
conglomerates of bone marrow were separated and homogenized using a 
sterile pipette.  The cells were plated on four 75cm2 culture plates and 
incubated in a humidified environment at 37°C and 5% CO2.  Non-adherent 
cells were removed three days later after the first media change.  Thereafter, 
the media was changed every 2 to 3 days.  When the cells became 75% 
confluent they were split into 3 new flasks indicating a new passage.  Cells 
used for seeding in the HUV were between passage 3 and 5. 
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4.2.4. Seeding of Constructs 
Decellularized HUV sections were immersed in standard media at 37°C 
24 hours prior to seeding MSCs were washed with 5ml of PBS and detached 
using 2 ml of 0.25% trypsin-EDTA (Invitrogen, Carlsbad, CA) for 5 minutes.  
The cell suspension was centrifuged at 2200 rpm for 5 minutes and the 
supernatant discarded.  The cell pellet was dissolved in media and mixed with 
type I collagen (Angiotech Biomaterials, Vancouver BC, Canada) to yield a 
final cell density of 1 million cells/ml and collagen concentration of 2 mg/ml. 
Special end adapters were designed to hold the HUV in place during the 
seeding procedure (Figure 4.3-a).  Using these adapters it was possible to 
insert the cellular collagen solutions into the HUV sections using a 1 ml 
pipette (loading volume 0.6 ml/HUV).  The seeded constructs (Figure 4.3-b) 
were placed in 100-mm diameter tissue culture plates where the collagen 
hydrogel polymerized for 1 hour.  Seeded HUV sections were then either 
immersed in 30 ml of standard media or mounted in a bioreactor and placed 
in an incubator at 37°C and 5% C02 for varying time durations of 1 and 2 
weeks (Figure 4.3-c).  A control group was included in which constructs were 
prepared as described above but without the use of cells.  Thus HUV sections 
in the control group were filled with acellular collagen hydrogel.  
 
Figure 4.3: (a) Novel design of an adapter to facilitate handling and seeding of HUV.  (b) 
HUV seeded with collagen and MSCs and cultured for 1 week.  (c) Cross section of 
seeded HUV 1 week post-culture.  Arrow points to cellular collagen hydrogel that was 
injected in the center of the HUV.   
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4.2.5. Cell Density 
The term “cellularity” is defined as the number of cells per construct.  At 
least three constructs per culture duration were tested for cellularity, with 
triplicate sections tested from each construct.  Sections were taken from the 
center and 1 cm away from the proximal and distal ends of the construct to 
avoid end effects.  Each 5 mm long ringlet was dissected into sections≤ 0.25 
mm2 and incubated with 2 ml of collagenase type I (MP Biomedicals, Solon, 
OH) for 5 hours at 37°C.  Following collagen digestion samples were 
sonicated for 1 minute and subjected to two cycles of freeze/thaw to ensure 
cells lyses and release of DNA into solution.   
DNA quantification was conducted by measuring the fluorescence of 
the different samples using a PicoGreen DNA quantification kit (Invitrogen, 
Carlsbad, CA) and a Synergy HT plate reader (Bio-Tek, Winooski, VT).  The 
kit included a buffer, a DNA standard, and a DNA dye.  For each solution to 
be tested for DNA content, triplicate samples were assayed to account for 
sampling error.  Five different DNA standard concentrations were employed 
(0, 0.1, 0.3, 1, and 3 µg/ml).  In a white, opaque 96 well plate 107µl of buffer 
solution was added in each well to be used, supplemented with 43 µl of 
sample and/or standard, and then incubated in the dark for 5 minutes with 150 
µl of dye solution.  The fluorescence of different wells was measures using the 
Synergy HT plate reader at a wavelength of 550nm.  The DNA concentration 
in µg/ml per cellular solution was computed through linear regression of the 
standard curve.  Concentrations were then converted to cell densities using 
Equation 4.1 and knowing that the DNA content per MSC was 3 pg/cell.  The 
PicoGreen DNA assay gives an indirect indication of cell viability by showing 
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an increase in DNA concentration, and thus an increase in cell number per 
construct, with time. 
3(pg/cell)
 g)(pg/10  (ml) Volume  g/ml)(ion concentratDNA 
  cells of #
6 µµ ××
=  
Equation 4.1: Computing cell number using the DNA concentration of a cellular 
solution. 
4.2.6. Light Microscopy 
Supplies for conducting histology including neutral buffered formalin, 
paraffin, clear-Rite, Hematoxylin and Eosin (H&E), and mounting media were 
purchased from Richard-Allan Scientific (Kalamazoo, MI).  Cords dedicated 
for histological evaluation were cut in two different directions: (1) cross 
sections corresponding to 5 mm thick ringlets, and (2) longitudinal sections 
corresponding to 5 mm thick portions cut parallel to the axial direction of the 
HUV.  Tissue samples were fixed in 10% neutral buffered formalin overnight 
at room temperature and stored in 70% ethanol no more than 2 weeks prior to 
embedding.  Fixed samples were dehydrated at 45°C in a series of increasing 
alcohol concentrations (70, 80, 95, and 100%), cleared with clear-Rite, 
infiltrated with melted paraffin at 60°C under vacuum, and embedded in 
paraffin blocks.  7-µm thick sections were sliced using a manual microtome, 
mounted on Histobond slides (VWR) and baked overnight at 45°C.  Use of the 
Histobond slides minimized tissue loss during H&E staining.  Tissue samples 
on slides were deparaffinized in clear-Rite, and then rehydrated in a series of 
decreasing alcohol concentrations.  Slides for light microscopy were stained 
progressively in hematoxylin, cleared in acid alcohol, counterstained in eosin, 
and finally dehydrated and secured by cover slips.   
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All slides were studied under a Nikon E800 microscope (Nikon 
Instruments, Inc., Melville,NY,USA).  Images were captured by a Nikon 
camera (Nikon Instruments, Inc.), and analyzed using the MetaMorph 
software V6.2 (Molecular Devices, Downingtown, PA, USA).   
4.2.7. Mechanical Testing 
Axial and radial mechanical testing was performed using a uniaxial 
tensile testing frame (United Testing Systems, model SSTM-2K, Flint, MI).  
Samples were preconditioned for 5 cycles to minimize hysteresis and then 
tested to failure at a strain rate of 1%/sec.  For radial testing 5-mm thick 
ringlets were dissected out of the construct, clamped to the machine using 
hooks, and stretched radially to failure.  For axial testing samples were 
hooked to the clamps using the steel adapters in order to avoid slippage.  A 1-
cm portion of the construct was attached to the adapter at each end with a 
gauge length of about 4 cm between clamps.  The gauge length and cross 
sectional dimensions were measured for each sample using digital calipers.  
Force and extension data were collected only from samples that failed in the 
region away from the clamps (Figure 4.4).   
 
Figure 4.4: Stretching a construct to failure. 
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4.2.8. Statistical Analysis 
For each culturing duration at least 3 samples were dedicated to cell 
density computations and histological evaluations (n≥3), and 6 samples for 
mechanical analysis (n≥6).  All results were expressed as mean values ± 
standard deviation.  Statistical analysis to compare results among groups was 
performed using the ANOVA method.  A significant difference corresponds to 
p<0.05 (confidence level >95%). 
4.3. RESULTS 
4.3.1. Proliferation of Cells 
Sections from three different locations on each of three seeded HUVs 
were tested for cellularity.  The coefficient of variance of the measured cell 
densities for the 3 sections was less than 12% (Figure 4.5).   
 
Figure 4.5: Coefficient of variance of cell density counts for three different constructs 
one and two weeks post culture.  Three sections per HUV were tested for cellularity.  
Sections were taken from the center, and 1 cm away from the proximal and distal ends 
of the construct to avoid end effects.  For both culture periods DNA quantification 
results for all three sections were similar with a coefficient of variance less than 12%. 
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A statistically significant increase in cell number was measured for the 
1 and 2 weeks culture time points (Figure 4.6).  The HUV was inoculated with 
600,000 cells. After 1 week in culture the total cell number increased to more 
than 1 million cells, and at the end of the two week culture period the total 
number of MSCs in the HUV exceeded 1.5 million.   
 
Figure 4.6: Cellularity of the HUVs cultured for different time points. 
4.3.2. Histology 
Decellularization was effective in removing cellular components.  This 
is clearly demonstrated in the H&E stained longitudinal sections of the HUV 
scaffold before (Figure 4.7-a) and after (Figure 4.7-b) decellularization.  
Numerous intact cells can be seen on the HUV prior to treatment (Figure 4.7 
3-a).  Upon decellularization no intact cell bodies are visible (Figure 4.7-b); 
however, fibers within the scaffold seem to be partially disrupted. 
Figure 4.7-c shows the morphology of acellular collagen gel in the 
central part of the control construct after 1 week of culture, while Figure 4.7-d 
shows the morphology of cellular collagen gel after 1 week of culture.  Cells 
are visible in the center of the HUV surrounded by the collagen hydrogel as 
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seen in Figure 4.7-e, with cells after 2 weeks migrating into the construct, 
Figure 4.7-f.  MSCs, denoted by circles, started integrating within the scaffold 
and migrating through the extracellular matrix (ECM) of the HUV. 
 
Figure 4.7: Histological images of HUV;  Longitudinal Sections of (a) initial matrix of 
HUV before decellularization and (b) matrix after decellularization.  The initial matrix is 
rich with cells, however, after decellularization no intact cells were obvious.  Cross 
sections of (c) acellular collagen gel matrix 1 week after being injected into the HUV, 
(d) MSC seeded collagen gel matrix 1 week after being injected into the HUV, (e) HUV 
one week after culture showing the injected collagen gel (arrows) and cells (circles) 
starting to integrate within the scaffold, and (f) HUV 2 weeks after culture showing the 
cells migrating toward the exterior portion of the cylindrical scaffold. 
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4.3.3. Mechanical Analysis 
Testing HUV constructs longitudinally and radially until failure resulted 
in a typical viscoelastic behavior due to the rearrangement of fibers upon 
stretching.  Thus the constructs were preconditioned for 5 cycles prior to 
loading till failure (Figure 4.8).  HUV sections were stronger in the longitudinal 
direction than in the radial direction.  Figure 4.9 shows a typical stress strain 
plot for HUVs tested in both directions.  While constructs are stronger and 
stiffer in the longitudinal direction, they stretch to a higher degree in the radial 
direction.  This is reflected by the low slope and high strain values for the plot 
of the radial direction.   
 
Figure 4.8: Toe region of stress-strain curves of HUVs preconditioned for (a) 5 and (b) 
10 cycles.  After 5 preconditioning cycles the load and unload paths became closer 
minimizing hysteresis. 
 
Figure 4.9: Typical stress stain curve of HUV.  The curve has a bell shape with a “toe” 
region (1), a “linear” region (2), maxima at ultimate stress (3), and a final decrease in 
strength at the failure point (4).  Both longitudinal and radial curves have similar 
trends; however, the longitudinal curve has a steeper slope (higher modulus), higher 
ultimate stress value, and lower strain value at failure. 
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Figure 4.10: Mechanical properties of the seeded HUV for different culture periods 
including tensile strength in the (a) longitudinal and (b) radial directions, and modulus 
of elasticity in the (c) longitudinal and (d) radial directions.  Tensile strength increased 
significantly in the longitudinal direction after 1 and 2 weeks of culture.  However, no 
significant change was recorded in the radial direction.  In both directions a significant 
increase in the modulus was measured after 2 weeks of culture indicating a stiffer 
material. 
Decellularization significantly increased the longitudinal ultimate stress 
of the HUVs from 0.6±0.1 MPa to 0.9±0.1 MPa (Figure 4.10-a).  Moreover, a 
statistically significant increase in the ultimate longitudinal stress values was 
observed 2 weeks post culture.  HUVs cultured for 1 week had an average 
ultimate stress value of 0.9±0.2 MPa as compared to 1.7±0.2 MPa for 2 week 
cultures.  This was not the case in the radial direction (Figure 4.10-b) where 
no change with culture time was observed.  An increasing trend in the 
stiffness in both directions of the seeded HUVs was observed after 1 and 2 
weeks of culture (Figure 4.10-c and Figure 4.10-d).  The longitudinal modulus 
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of elasticity increased from 6.3±0.5 MPa 1 weeks after culture to 9.1±1.8 MPa 
after 2 weeks.  Similarly, an increase in the radial direction was recorded from 
0.8±0.1 MPa to 1.8±0.5 MPa.   
4.3.4. Discussion 
The goal of this study was to investigate the potential of the HUV as a 
biological scaffold for soft musculoskeletal tissues, particularly tendons and 
ligaments.  The documented results show that it was possible to decellularize 
the HUV with minor disruptions to the ECM.  Moreover, the HUV was shown 
to support cell integration and proliferation as histological analysis revealed 
cell migration from the center of the HUV into the scaffold, and a progressive 
increase in cell density over the 2 weeks culture period.  Finally, culturing 
MSCs within the HUV scaffold for periods up to 2 weeks was shown to 
significantly increase the mechanical properties of engineered constructs. 
Histological images showed adequate decellularization of tissue with 
minor disruption to ECM components.  No intact cell bodies appeared post 
treatment with SDS (Figure 4.7-b).  This is in agreement with previous studies 
reporting that the ionic surfactant SDS is efficient in removing and solubilizing 
cellular components including cytoplasmic proteins and nuclear debris from 
tissue186,194.  Even though SDS was found to disrupt ECM proteins, 
decellularized tissues usually maintained their mechanical properties194.  
Decellularized HUV sections had similar stiffness but were 40% stronger than 
the cellular tissue.  The increase in ultimate stress is possibly due to the 
dehydration of the tissue with ethanol195. 
The decellularized HUV has proven to support cell integration and 
proliferation since MSCs were able to populate the scaffold.  After one week 
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of culture the cell density increased 1.8 fold and that increase became 2.5 fold 
after 2 weeks of culture (Figure 4.6).  MSCs seem to be uniformly distributed 
along the longitudinal axis of the construct.  Uniformity of cells through the 
construct was evaluated with DNA quantification tests in three different 
sections taken from the proximal, distal and mid-section of each construct.  
The three different sections yielded comparable cell densities, with a 
coefficient of variance less than 12% (Figure 4.5).  The measured increase in 
the cellularity of the constructs 1 and 2 weeks post culture was also reflected 
in cross sectional histological images.  H&E sections (Figure 4.7-e) revealed 
cells attached to the inner wall of the HUV and others populating and filling 
the central area of the scaffold.  After two weeks of culture (Figure 4.7-f) 
MSCs migrated through the HUV matrix populating the scaffold and possibly 
remodeling the ECM.  The characteristic random orientation of collagen fibers 
shown in Figure 4.7-c has significantly changed in the presence of cells 
(Figure 4.7-d) denoting ECM remodeling. 
The increase in cellularity, ECM remodeling, and cell migration through 
the HUV were accompanied with an increase in the mechanical properties of 
the constructs.  There was no significant increase in strength after one week 
of culture.  This is likely due to cells adapting to the new environment.  
However, a 95% increase in the ultimate stress and 80% increase in the 
modulus were measured two weeks post culture.  The increase in mechanical 
strength is not directly related to the increase in cell number.  One week post 
culture the increase in cellularity was 79%; however there was no significant 
increase in ultimate stress.  After 2 weeks of culture the cell number within the 
constructs almost doubled again.  This time the cell number increase was 
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accompanied by a 92% increase in the ultimate stress.  During both 
conditions there was a comparable increase in cell number however only in 
the second week did the ultimate stress increase.  This suggests that the 
increase in mechanical strength is related to the activity of the cells within the 
construct.  Potential ECM deposition and remodeling of existing ECM matrix 
by the second week of culture may be responsible for the enhancement of the 
mechanical properties of the construct.   
The non-linear tensile behavior of the HUV is typical of soft biological 
tissues41,79.  During load-unload cycles there is a dissipation of energy due to 
the rearrangement of the fibers within the scaffold, namely collagen.  
Constructs were preconditioned for 5 and 10 cycles.  The energy dissipated 
was minimal after 5 preconditioning cycles where load-unload curves almost 
followed the same trajectory (Figure 4.8).  Thus only 5 preconditioning cycles 
were applies prior to stretching the samples to failure.  Mechanical testing 
yielded significantly higher modulus and ultimate stress values in the 
longitudinal direction than in the radial direction.  Such differences were 
previously reported on manually dissected79 as well as mechanically 
dissected HUVs134.  Longitudinal ultimate stress values for decellularized 
HUVs were 26% higher than the radial direction (0.9±0.1 MPa compared to 
0.7±0.2 MPa).  Two weeks post culture the longitudinal ultimate stress 
became 167% higher than the radial strength.  The elastic modulus for 
decellularized HUVs was 4 times higher in the longitudinal direction than in 
the radial direction (3.3±0.6 MPa compared to 0.8±0.2 MPa).  Two weeks post 
culture the longitudinal elastic modulus became more than 5 folds stiffer than 
the radial modulus (9.0±1.9 MPa compared to 1.8±0.5 MPa).  The ultimate 
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stress values reported in this study for the decellularized HUVs are in 
agreement with the results reported in a previous study that characterized the 
mechanical properties of manually dissected HUVs79.  Pennati79 reported 
longitudinal ultimate stress values of 1.6 ±1.1 MPa that were much higher 
than the radial ultimate stress values (0.5 ±0.1 MPa).  In that study HUVs 
were manually dissected to a thickness of 4mm, 5 times thicker than our 
mechanically dissected cords (0.75mm thick).  This explains the higher 
longitudinal ultimate stress value reported.  However, it is interesting to note 
the variability in the ultimate stress values reported by Pennati79 which had 
67.3% coefficient of variance compared to 16.3% for our mechanical 
technique.   
The fact that HUVs are stronger and stiffer in the longitudinal direction 
reflects the possibility of using them as a scaffold for engineering tissue that 
requires higher strength values in the longitudinal direction; such as tendons, 
and ligaments.  It is possible to enhance the mechanical properties of the 
decellularized scaffold by increasing the thickness of the dissected HUV.  This 
is simply accomplished by adjusting the thickness control on the automatic 
lathe.   
4.4. CONCLUSIONS 
The scaffold presented in this study supported cell integration, 
proliferation and migration.  The seeded constructs possessed higher 
mechanical properties than the original decellularized HUV.  These 
mechanical properties could be enhanced by increasing the initial thickness of 
the scaffold or increasing the seeding density.  The use of MSCs in this study 
is due to their ability to differentiate into specific lineages, including soft 
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musculoskeletal tissue, depending on the mechanical and chemical stimuli 
that they are subjected to.  Thus coupling the use of the decellularized HUV 
scaffold, with MSCs stimulated by the appropriate biochemical or biophysical 
factors opens up many opportunities for exploiting this readily available 
biological material.   
In Chapter 5 the effects of cyclic mechanical stimulation on the seeded 
HUV are documented.  Moreover, the potential of the resulting construct to act 
as a tissue engineered tendon is assessed. 
 
53 
CHAPTER 5 
TENDON TISSUE ENGINEERING USING CELL SEEDED UMBILICAL 
VEINS CULTURED IN A MECHANICAL STIMULATOR 
The contents of this chapter were published in Tissue Engineering, 
volume 15, issue TBD, pp. TBD, 2009. 
5.1. INTRODUCTION 
Tendon injuries affect thousands of individuals annually.  Athletes, in 
particular, are prone to Achilles tendon injuries3, with more than 232,000 
injuries documented in 20024.  One quarter of Achilles tendon injuries 
reported by athletes require surgery and almost one fourth of those who 
undergo surgery require further future operations4.  Lacking an inclusive 
vascular network67 and composed of cells with low metabolism24, tendons 
have poor intrinsic healing capabilities5,8, and when healing is possible, it 
requires prolonged durations of rest and immobility.  The healing tendon 
develops scar tissue with reduced mechanical strength and is prone to further 
injury if used extensively or repetitively.  When tendon replacement is 
inevitable there are four material options available: autografts, allografts, 
xenografts, and prosthetic devices.  Autografts have limited availability, 
weaken the donor site, and result in a double incision that inflicts additional 
pain on the patient, while allografts and xenografts often result in an immune 
response.  Prosthetic devices, on the other hand, are a temporary solution 
since their integrity is compromised with increased usage89.  To augment the 
limitations in the current treatments of tendon defects and injuries, 
researchers have attempted to engineer tendon-like tissue in-vitro that 
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possesses comparable mechanical properties to the innate tissue and that 
would evade the immune response. 
Since immobilization severely lowers the ultimate strength of tendons91, 
current research has focused on the effect of stretching cell seeded 
constructs to enhance mechanical properties13,98,155,196.  In a recent 
investigation two-dimensional tissue sheets secreted by human fibroblasts 
were subjected to continuous (non-cyclic) mechanical loading; results showed 
that cells and the extracellular matrix (ECM) became aligned and increased 
both the tensile strength and modulus of the tissue158. Mechanical stimulation 
of collagenous constructs seeded with Mesenchymal Stem Cells (MSCs) has 
also been shown to increase the expression of ligament and tendon 
markers94,177, indicating the potential of MSCs to differentiate into tenocytes 
under the sole action of mechanical stimulation.  However, poor mechanical 
properties of cultured collagen gel constructs prevent their use as tendon 
replacements178.   
Biological scaffolds, such as small intestinal submucosa131,132, collagen 
fibers133, and Human Umbilical Veins (HUVs)134, have been targeted for tissue 
engineering applications since they are biocompatible, evade the immune 
response, and have initial ultimate stress and stiffness values significantly 
higher than collagen gels.  It has been shown that HUV provides a suitable 
environment for musculoskeletal tissue engineering applications (CHAPTER 
4).  In this study we investigate the effect of cyclic mechanical stimulation on 
HUVs seeded with MSCs.  To accomplish our goals a bioreactor was 
designed to cyclically tension the seeded scaffolds for periods of 1 and 2 
weeks.  We hypothesize that cyclic mechanical tensioning would increase 
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MSCs proliferation rates and enhance the mechanical and morphometric 
properties of seeded HUVs giving them the potential to act as tendon 
replacement models.   
5.2. MATERIALS AND METHODS 
5.2.1. Bioreactor Design 
A Mechanical Stimulator for Tissue Engineering applications (MSTE) 
was designed specifically for this project.  The main goals behind constructing 
the MSTE were; (1) to culture multiple tissue constructs under a sterile 
environment, and (2) to apply controlled mechanical stimuli at different 
frequencies, intensities, and waveforms to cell seeded scaffolds.  The MSTE 
is capable of stimulating triplicate constructs simultaneously (Figure 5.1-a).  
Three samples cultured in separate vessels can be tensioned via a linear 
actuator controlled by a signal converter (Wavetec model 185, San Diego, 
CA).  The applied signal is amplified before being transferred to the actuator 
(Figure 5.1-b).  The specifications of the actuator are: linear travel zone = 5 in, 
peak force sustained for 10 seconds = 49 lb, and maximum force sustained 
continuously = 14 lb.  Using the signal converter box (Figure 5.1-c) it is 
possible to apply several waveform signals with variable frequencies and 
amplitudes. 
The cylindrical reactor vessels were made of glass (diameter = 2.5 cm, 
length = 10 cm) with an individual capacity of 49 ml.  The total volume of 
media circulated through the system is 240ml.  Media is flowed around the 
constructs continuously using a multi channel pump at the rate of 1 ml/min.  
Two media reservoirs are used to re-circulate the media around the MSTE 
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perfusion circuit.  The use of the two-reservoir system facilitates the 
procedure of changing the media without having to move the system out of 
the incubator. Keeping the bioreactor in place in a closed environment 
minimizes contamination events.  A filter on the media container and gas-
permeable silicone tubing allow media oxygenation.  The whole system is 
kept in a humidified incubator at 37ºC, 5% CO2, and 95% air.    
 
Figure 5.1: (a) Design of the Bioreactor, (b) Linear Motor, (c) Amplifier and signal 
converter, and (d) Close up to the reactor vessels. 
The load is transferred from the actuator to the samples via a piston 
that connects to a triangular plate which in turn is hooked to the three 
constructs (Figure 5.1-d).  The samples are attached to the triangular plexi-
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glass plate via stainless steel adapters that can be screwed up or down to 
adjust the height of each sample separately accounting for individual plastic 
deformations upon stretching.  To seal the top of each reactor vessel surgical 
gloves were used.  The three middle finger portions of the surgical gloves 
were cut, and then attached to the top of the vessel from one side and to the 
stainless steel adaptors from the other side using zip-ties (Figure 1-d).  All of 
the materials used to assemble the bioreactor can be sterilized either by 
ethylene oxide or steam (stainless steel adapters, glass bottles, plexi-glass 
bases, glass reactor vessels, zip ties, and surgical gloves).   
5.2.2. Preparation of the Scaffold 
Refer to sections 4.2.1 and 4.2.2 
5.2.3. Extraction of MSCs 
Refer to section 4.2.3 
5.2.4. Seeding of Constructs 
Refer to section 4.2.4. 
Cell attachment and polymerization of collagen were allowed for a full 
hour after which the seeded constructs were divided into three groups as 
follows: (Group 1) Seeded HUVs were placed in 100-mm diameter well plates; 
(Group 2) Seeded HUVs were cultured in the MSTE without any mechanical 
stimulation; (Group 3) Seeded HUVs were cultured in the MSTE and 
subjected to mechanical stimulation of 2% strain for 1 hour per day at a 
frequency of 0.0167Hz.  A fourth group (Group 4) consisted of acellular 
unseeded HUVs that were mechanically stimulated in the MSTE.  Constructs 
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were cultured for durations of 1 and 2 weeks and then tested for (1) cell 
density, (2) gene expression, (3) morphology, and (4) mechanical properties. 
5.2.5. Cell Density per Construct 
Refer to section 4.2.5 
5.2.6. Ribonucleic Acid Extraction and RT-PCR  
Tissue samples (≤ 25 mg) dedicated for gene expression analysis were 
stored in 1.5 ml of RNAlater® (Ambion, Austin, TX) at -20°C to preserve 
Ribonucleic Acid (RNA) until further analysis.  RNA was extracted from the 
tissue using an RNAqueous®-4PCR Kit (Ambion) following manufacturers 
directions.  cDNA was synthesized from RNA using TaqMan® Reverse 
Transcription Reagents (Applied Biosystems, Austin, TX) in the presence of 
multiscribe reverse transcriptase (50 U/µl), RNase inhibitor (20U/L), 
deoxyNTPs mixture (2.5 mM), random hexamers (50µM), 10X buffer, and 
MgCl2 solution (25 mM).  Gene expression levels of collagens type I and type 
III, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were 
quantified using a Power SYBR® Green PCR Master Mix kit (Applied 
Biosystems).  Primers used were as follows:  
Collagen type I: forward 5’-GGAGAGTACTGGATCGACCCTAAC-3’’197 
Collagen type I: backward 5’-CTGACCTGTCTCCATGTTGCA-3’’197;  
Collagen type III: forward 5’-CAGCTGGCCTTCCTCAGACTT-3’198, 
Collagen type III: backward:5’-GCTGTTTTTGCAGTGGTATGTAATGT-3’198 
GAPDH:  forward 5’-AACTCCCTCAAGATTGTCAGCAA-3’198 
GAPDH:  backward 5’-GTGGTCATGAGCCCTTCCA-3’198.  
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Quantitative real time polymerase chain reaction (qRT-PCR) was 
conducted according to the following steps: 95°C for 10 minutes, 45 cycles of 
95°C for 15 minutes and 60°C for 1 minute.  At the end of RT-PCR, melting 
curves were generated for each amplified product.  The threshold cycle (CT) 
for collagens type I and III was normalized to the housekeeping gene GAPDH 
and the relative expression was computed following the ∆∆CT method199 . 
5.2.7. Light Microscopy 
Refer to section 4.2.6 
5.2.8. Fluorescent Microscopy 
Tissue samples on slides dedicated to fluorescent microscopy were 
deparaffinized in clear-Rite, rehydrated in a series of decreasing alcohol 
concentrations, and then they were incubated for 30 minutes in the dark at 
37°C with 100 µl of dye solution.  The dye solution was composed of 5µl of 
lipophilic stain DID (Invitrogen) and 1 ml of media.  Tissue samples were 
finally washed three times in media (10 minutes per wash).   
All slides were studied under a Nikon E800 microscope and images 
were captured by a Nikon camera and analyzed using the MetaMorph 
software V6.2.  An omega XF110 optical filter (Omega Optical, Brattleboro, 
VT) was employed to detect the fluorescence of the DID dye with an 
excitation wavelength of 644 nm and an emission wavelength of 665 nm.  
Using high excitation and emission wavelengths was necessary to avoid 
background autofluorescence from the tissue.  
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5.2.9. Analysis of Histological Slides 
Three main criteria were followed to analyze histological slides.  For 
each criterion the analysis was done on at least three slides and four different 
locations per slide were studied.   
Unoccupied luminal space:  The unoccupied luminal space in the 
central portion of the HUV was measured and reported as a percentage of the 
ratio of the central area that is devoid of cells and matrix to the total cross 
sectional area of the HUV.  This parameter was monitored to evaluate the 
formation of new ECM in the central portion of the HUV beyond the collagen 
hydrogel that was originally inserted.  For that reason, values of this 
parameter in decellularized HUV were compared with those of seeded HUV at 
different time points. 
Fiber alignment:  To analyze fiber alignment the axial direction of the 
HUV, which is parallel to the direction of mechanical stimulation, was 
considered the reference axis.  The angular deviation of fibers from the axial 
direction was measured and the mean with the standard deviation were 
reported. 
Shape of cells:  Using the Metamorph program it was possible to count 
the cells that appear in a longitudinal slide and compute their dimensions 
(length, width and area).  The shape factor is a measure of the ratio of the 
shorter dimension (width) to the longer dimension (length).  This number is 
smaller than one.  The closer it is to one the more round the shape of the cell 
is.   
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5.3. RESULTS 
5.3.1. Cell Proliferation and RT-PCR 
The culturing conditions of the four different groups are summarized in 
Table 5.1.  For all seeded groups and all culturing durations a statistically 
significant increase in cell number was measured (Figure 5.2).  After 1 week 
of culturing, group 1 (constructs cultured statically in a Petri dish) had the 
lowest cell density.  The total cell number increased from 600,000 MSCs to 
1.1±0.1 million cells for group 1, 2.1±0.4 million cells for group 2 (constructs 
cultured in the MSTE without tensioning), and 1.8±0.2 million cells for group 3 
(constructs tensioned in the MSTE).  However, after 2 weeks of culture, group 
3 had more than 29 million cells compared to 1.6±0.2 million cells in group 1 
and 3.6±2.0 million cells in group 2. 
Table 5.1: Four different groups with varying culture conditions. 
GROUP CULTURE CONDITION 
1 Seeded HUV’s cultured in 100-mm diameter well plates 
2 Seeded HUV’s cultured in MSTE without any mechanical stimulation 
3 Seeded HUV’s mechanically stimulated in the MSTE 
4 acellular unseeded HUV’s mechanically stimulated in the MSTE 
 
qRT-PCR conducted after 2 weeks of culture showed an upregulation in the 
expression of both collagen I (4 fold) and collagen III (3 fold) in stretched 
constructs of group 3 compared to groups 1 and 2. 
5.3.2. Histology 
Figure 5.3 shows cross sections of the HUV, before and after 
decellularization, fluorescently tagged by the DID dye.  Numerous cells 
appear in Figure 5.3-a reflecting the Wharton’s Jelly and HUV cells originally 
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present in the umbilical cord prior to decellularization.  However, no intact 
cells were apparent in Figure 5.3-b after decellularizing the HUV.   
 
Figure 5.2: Proliferation of cells after 1 and 2 weeks of culture 
 
Figure 5.3: Cross sectional view of the HUV stained with DID lipophilic dye (a) cellular 
HUV, and (b) Decellularized HUV 
Cross sectional histological images of constructs cultured statically in 
the MSTE (Figure 5.4-a) showed large unoccupied spaces in the central 
portion of the HUV compared to dynamically cultured samples (Figure 5.4-b) 
in which the central area was almost totally occupied with proliferating cells.  
The decellularized HUV had a cylindrical structure with a central unoccupied 
luminal space of 14 ± 4.0 %.  After 2 weeks of culture the unoccupied luminal 
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space significantly decreased to 5.7±2.0% for group 3 (Figure 5.5).  No 
statistically significant decrease was measured for group 2.  For all cultures, 
cells were able to integrate with the HUV and migrate through the scaffold.  
For group 2 cells only reached the first quarter of the scaffold (Figure 5.6-a) 
whereas cells seeded in group 3 (constructs stimulated in the MSTE) 
migrated deep into the scaffold almost reaching the outer end of the HUV 
(Figure 5.6-b). 
 
Figure 5.4: Cross section of constructs cultured for 2 weeks in the MSTE under (a) 
static conditions; (b) mechanical stimulation 
Longitudinal histological sections show ECM fiber alignment for static 
and dynamic cultures (Figure 5.7).  For static cultures, ECM fibers had 
random orientations 1 (Figure 5.7-a) and 2 weeks (Figure 5.7-b) post culture.  
Contrarily, mechanically stimulated constructs showed parallel alignment of 
fibers for both culture periods (Figure 5.7-c and Figure 5.7-d).  After two 
weeks of culture, the average fiber deviation from the axial direction was 
measured to be 1.7°±1.8° for mechanically stimulated samples (Figure 5.8-b), 
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while this value was 34°±48° for static cultures (Figure 5.8-a).   A closer view 
at the longitudinal sections showed rounded nuclei for cells in the static 
cultures (Figure 5.8-c) with a shape factor of 0.9 compared to spindle shaped 
nuclei for the dynamic cultures with a shape factor of 0.7 (Figure 5.8-d).   
 
Figure 5.5: Percent of unoccupied luminal space in the seeded constructs cultured in 
the MSTE. 
 
 
Figure 5.6:  Histological cross sections of seeded HUV after 2 weeks of culture in 
the MSTE: (a) static, and (b) dynamic.  
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5.3.3. Mechanical Analysis 
Mechanical properties were assessed by stretching HUV constructs to 
failure while recording deformation versus load data.  After 1 week of culture a 
statistically significant increase in the ultimate tensile stress values was 
recorded for all cellular groups (Figure 5.9-a).  Group 3 had the highest 
ultimate stress value 2 weeks post culture (2.6±0.7 MPa).  No significant 
increase in ultimate tensile stress was measured for acellular dynamic 
samples (Figure 5.9-b). 
 
Figure 5.7: Longitudinal sections of HUVs cultured in the MSTE taken at 4X 
magnification. (a) 1 week static culture, (b) 2 weeks static culture, (c)1 week dynamic 
culture, (d) 2 weeks dynamic culture.  Arrows indicate stretching. 
A similar trend was observed for modulus of elasticity (E) values 
(Figure 5.10).  Decellularized scaffolds had a modulus of elasticity E = 3.3±0.6 
MPa.  After 2 weeks of culture group 1 had E = 9.0±1.9 MPa, group 2 had E = 
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7.3±2.4 MPa, and group 3 had the highest modulus value of 9.9±2.2 MPa.  
Acellular samples of group 4 had inferior modulus of elasticity values (Figure 
5.10-b) compared to other groups.  One week after culture the modulus 
decreased from 3.3±0.6 MPa to 2.9±1.4 MPa.  This value further decreased to 
2.4±0.5 by the end of the second week of culture. 
 
Figure 5.8: Longitudinal sections of HUVs cultured in the MSTE taken at higher 
magnifications. (a and b) 10X magnification of the HUVs revealing fiber alignment for 2 
week static and dynamic cultures, respectively.  (c and d) show shape of nuclei for 
static and dynamic cultures respectively, 2 weeks post culture at a 20X magnification.  
Arrows indicate stretching direction and circles indicate cell nuclei. 
5.4. DISCUSSION 
The goal of this study was to investigate the effect of cyclic mechanical 
stimulation on MSC seeded HUVs and to assess the construct’s potential as 
an engineered tendon replacement.  We hypothesized that cyclic mechanical 
tensioning would (1) increase MSCs’ proliferation rates, (2) modify the 
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morphometric characteristics of seeded HUVs giving them a tendon-like 
appearance, and (3) enhance the mechanical properties of the construct.  
 
Figure 5.9: Ultimate tensile stress of (a) cellular groups (1-3), and (b) dynamically 
stimulated groups (3 and 4).  
 
Figure 5.10: Elastic modulus of (a) cellular groups (1-3); and (b) dynamically stimulated 
groups (3 and 4) 
For all cellular groups a statistically significant increase in the cell 
number was measured indicating that MSCs were able to proliferate within the 
scaffold (Figure 5.2).  Mechanical stimulation significantly increased cell 
proliferation over the 2 week culture period by at least 8 fold.  Under similar 
loading conditions, canine tendons deprived from stretching showed a 
decreased cell density compared to mechanically stimulated tendons91.  In 
several other studies it was reported that mechanical stimulation increased 
proliferation rates of MSCs94,98.  Stretching the constructs may have a direct 
or an indirect effect on the cells, where applying a shearing load may affect 
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surface receptors and/or stretch activated ion channels16 leading to an 
increase in proliferation rates.  Another explanation could be that cyclic 
loading enhances mass transport through the HUV thus mitigating potentially 
existing mass transport limitations of nutrients.  Contrary to our findings, 
Androjna et.al reported no significant effect of mechanical stimulation on 
proliferation rates of primary tenocytes seeded on small intestinal 
submucosa131.  The disagreement between the two studies could be due to 
differences in cell and scaffold type, and mechanical stimulation scenarios.  
Interestingly, after 1 week of culture group 2 (constructs cultured in MSTE 
without stimulation) had the highest cell number among all 3 groups.  Initial 
stretching of the constructs after seeding may have caused some cells to 
detach from the matrix resulting in lower cell numbers in group 3 compared to 
group 2 after the first week of culture. 
For all time points group 1 (constructs cultured in a Petri dish) had the 
lowest cell number compared to the other 2 groups that were cultured in the 
MSTE statically and dynamically.  Constructs in group 1 were lying horizontal 
with their bottom part touching the Petri dish and stagnant media covering the 
rest of the constructs.  Groups 2 and 3, on the contrary, were cultured in the 
MSTE with media continuously flowing around the samples on all sides.  The 
lower cellularity in group 1 could imply the presence of external mass 
transport limitations to the HUV.   
The significant increase in cell number after 2 weeks of culture for 
dynamic samples over static controls was also reflected in histological 
analysis.  The unoccupied luminal space in the middle portion of the HUV 
remained almost unchanged for the static cultures of group 2 (Figure 5.5) 
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compared to a 50% decrease for mechanically stimulated constructs in which 
proliferating cells within collagen matrix filled up the central portion of the 
scaffold (Figure 5.4-b).  The increase in ECM deposition was also reflected in 
RT-PCR results where collagen types I and III were upregulated 4 and 3 fold, 
respectively, in tensioned samples compared to the static cultures.  Cells 
within mechanically stimulated constructs penetrated almost 75% of the 
thickness of the HUV unlike the static controls where this penetration was 
limited to the first quarter of the scaffold (Figure 5.6).  Clearly mechanical 
stimulation enhanced the migratory capacity of MSCs into the tortuous porous 
network of the HUV extracellular matrix.  Mechanical stimulation had also an 
effect on fiber alignment and cell shape within the scaffold (Figure 5.7 and 
Figure 5.8).  Stretching the samples aligned collagen fibers parallel to each 
other and gave the cells a spindle shape (shape factor of 0.7) mimicking the 
morphology of native tendons200 while fibers of static controls had a random 
orientation and the cells remained round typically like MSCs201.  Stretching of 
the nuclei of the MSCs could be an indication of their differentiation in to a 
specific lineage, namely tenocytes94.  Several cell types have been widely 
found to respond to mechanical stimuli5,103.  It has been suggested that the 
shape of the cell and its nucleus are governed by cytoskeletal tension16,202.  
Nuclei of native tendons that were deprived for two weeks from stretching 
transformed from elongated to rounded91.  Upon the application of longitudinal 
force to tissue constructs, cells aligned in the direction of stretching158,179,180 
giving the construct a tendon-like appearance13.  Human fibroblasts plated on 
RGD coated silicone dishes were mechanically stimulated with varying 
loading values (0%, 4%, 8%, and 12% strain) at 1 Hz for 24 hours.  Straining 
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substrates at a higher percent lengthened cells and resulted in an increase in 
their alignment180. 
All cellular groups had improved mechanical properties 1 and 2 weeks 
post culture, showing that the presence of cells in the scaffold contributed to 
the increase in the strength and stiffness of the seeded HUVs.  De-novo 
secreted ECM and generated contractile forces through adhesion proteins are 
two ways in which cells could contribute to the increase in mechanical 
properties of the constructs131.  Stretching significantly improved the 
mechanical properties of cellular constructs of group 3 compared to groups 1 
and 2.  The ultimate tensile stress and modulus of elasticity values for 
tensioned constructs were at least 1 fold higher than untensioned constructs 
after 2 weeks of culture (Figure 5.9-a and Figure 5.10-a).  The significant 
increase in mechanical properties of the stimulated samples compared to all 
the controls was due to the combined effect of stretching and the presence of 
cells within the constructs.  Stretching collagenous tissues or polymeric 
scaffolds has previously been found to align the in-vitro synthesized or 
already existing fibers in a parallel manner improving the mechanical 
properties of the biotissue75,181,203.  Mechanically stimulating MSC seeded 
collagen gels for 2 weeks increased their linear modulus 4 folds compared to 
the untensioned controls203.  Similar results were reported when rat knee 
patellar tendons, transplanted into the subcutaneous tissue, were cyclically 
tensioned for 4 weeks181.   
To determine whether the presence of cells played a role in improving 
mechanical properties of tensioned constructs group 4 was introduced.  
Acellular scaffolds were dynamically cultured in the MSTE in the same 
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manner and under the same conditions as group 3.  If the increase in 
mechanical properties (ultimate tensile stress and modulus of elasticity) was 
solely due to stretching then group 4 should have similar mechanical 
properties as group 3.  However, after 2 weeks of culture group 4 had an 
ultimate tensile stress of 1.4±0.5 MPa significantly lower than group 3 
(2.6±0.7 MPa).  Similarly, the modulus of elasticity for group 4 was 4 fold 
lower than that of group 3.  Our results are in agreement with previous studies 
which reported that the presence of cells significantly increased the 
mechanical properties of collagen scaffolds133.  
After 2 weeks of stimulation, the resulting constructs in this study had 
ultimate tensile strength values only 1 order of magnitude lower than human 
tendons (50-125 MPa)41,130 and within the range of ultimate strain of human 
tendons (9%-35%)41 (Table 5.2).  Moreover, the HUV scaffold had a 
characteristic toe region in the stress-strain curve reflecting crimp, which is an 
extremely important property of tendons and ligaments because it allows the 
soft tissue to briefly stretch before it acquires significant force, thus protecting 
the muscle and the joints35.  The results obtained are promising and could 
lead to bio-artificial tendon tissue cultured in-vitro with the careful optimization 
of potentially critical culture parameters such as seeding density, loading 
regimes, and stretching durations.   
Table 5.2: Strain at ultimate tensile stress for different groups. 
 Strain at Ultimate Tensile Stress 
Culturing Duration Group 1 Group 2 Group 3 
1 week 27 ± 10 22 ± 3.0 21 ± 9.0 
2 weeks 29 ± 9.0 20 ± 6.0 24 ± 2.0 
 
A limitation of the current design is the lack of incorporating a 
transitional region that allows fixation of the construct to the bone.  The major 
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function of tendons is to transmit loads from the soft tissue to the bone, thus 
failure to fix the engineered construct to the bone might render the bio-artificial 
tendon dysfunctional35.  In an attempt to reproduce and better understand the 
bone to soft tissue attachment region, a number of studies were conducted in 
which osteoblasts, fibroblasts204,205, and chondrocytes206 were co-cultured.  
Several fixation methods of soft tissue to bone were investigated including 
staples, sutures, screws207,208, and soft tissue plates208.  Screws were 
reported to give superior results over the rest of the choices.  After attaching 
soft tissue engineered constructs into bone via insertion through a drilled bone 
tunnel, bone growth into the construct was observed209,210.  Therefore, it is 
possible that upon implanting the HUV tendon model in-vivo, the segment that 
is enveloped by the bone tunnel would calcify due to signaling effects from 
cells at the insertion point, giving the construct enough strength at the 
enthesis.  Further research is required to fully understand these mechanisms. 
5.5. CONCLUSIONS 
Results have shown the ability of MSCs to proliferate and migrate deep 
into the HUV scaffold when subjected to stretching.  After 2 weeks of culture 
an increase in cell number was measured for all groups, however the increase 
was at least 8 folds higher for tensioned constructs.  Mechanically stimulating 
constructs with 2% strain for one hour per day increased the proliferation rate 
of MSCs and gave the construct a tendon like appearance.  Histological 
images showed ECM fibers and cell nuclei aligned parallel to the direction of 
stretching mimicking the morphology of native tendons.  Moreover, 
mechanostimulation resulted in significantly stronger and stiffer constructs 
compared to un-tensioned samples.  It is recommended in future work to 
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investigate mass transport of nutrients through the HUV to better understand 
the relationship between mechanical stimulation and cell proliferation.   
In Chapter 6 the diffusion of nutrients and biomolecules, having a wide 
range of molecular weights, through the different layers of the HUV is 
investigated.  
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CHAPTER 6 
DIFFUSION OF NUTRIENTS AND BIOMOLECULES THROUGH THE 
HUMAN UMBILICAL VEIN 
6.1. INTRODUCTION 
The human umbilical cord has been recently documented as a source 
of stem cells and biological scaffolds for tissue engineering.  Wharton’s Jelly 
cells have been classified as stem cells that could differentiate into different 
lineages including adipose105,211, bone105,211,212, cartilage105,211,212, 
cardiac105,213 and neural117,212,214 tissue.  The Wharton’s Jelly matrix is rich 
with collagen137, proteoglycans138,139, and growth factors136,140,141 and could 
potentially evade the immune response215,216, which makes the human 
umbilical vein an attractive biological scaffold for tissue engineering 
applications.  The Human Umbilical Vein (HUV) has been used as a scaffold 
for nerve217, cardiovascular134,218-220, as well as, soft musculoskeletal79 tissue 
engineering constructs.  In most of in vitro tissue engineering applications the 
cells are seeded in the central portion of the HUV while nutrients are supplied 
at the external surface of the scaffold.  As a result, the transport of nutrients 
and growth factors through the wall of the scaffold is critical for cell survival, 
proliferation and migration into the interior of the HUV, and for final construct 
biological and biomechanical properties.   
In most tissue engineering applications the HUV is decellularized prior 
to being used as a biological scaffold134,217.  Thus, to better simulate the 
diffusion of nutrients and biomolecules through this novel scaffold, the HUV 
was used in its decellularized form.  Since the HUV is a multilayer biological 
tissue mainly composed of the WJ matrix and the wall of the vessel, glucose 
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permeability through the HUV wall was compared to that through the 
Wharton’s Jelly matrix to determine which layer controls the rate of nutrients 
diffusion.  Moreover, to better understand mass transport through this 
material, the permeability of the HUV to FITC-Dextran molecules spanning a 
wide range of molecular weights was measured.  To our knowledge, this is 
the first published attempt to characterize the diffusion of nutrients through the 
different layers of the HUV, and measure the permeability of the HUV 
membrane to molecules of different molecular weights.  
6.2. MATERIALS AND METHODS 
6.2.1. Preparation of the HUV 
Refer to sections 4.2.1 and 4.2.2. 
Before being placed in the diffusion chamber the HUV was cut open 
along its longitudinal axis, and dissected into squares having a side length of 
approximately 1.5 cm.   
6.2.2. Experimental Setup 
A side-by side diffusion chamber was designed to allow the 
measurement of the effective diffusivity through the HUV.  The setup was 
previously used to measure the permeability of small intestinal submucosa221.  
However, the apparatus had to be modified to fit the dimensions of the HUV.  
The set up consisted of two cylindrical chambers having a diameter of 9.5 
mm, a length of 3.5 cm, and an individual volume of 2.5 ml (Figure 6.1).  A 
1.0±0.2 mm thick square section of HUV was placed between the two 
chambers.  The molecule of interest was loaded in the first chamber, with a 
predetermined concentration, facing the luminal side of the HUV, and 2.5ml of 
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nano pure water were loaded in chamber 2 facing the ab-luminal side of the 
HUV.  This layout for the HUV membrane was chosen because in 
musculoskeletal applications media was supplied to the construct at the 
luminal side of the HUV, and nutrients had to diffuse through the membrane 
thickness to the central portion where the cells were inoculated. 
Two different solutions were used for the measurements of the 
apparent diffusion coefficient.  The first solution was FITC-conjugated dextran 
molecules with three different molecular weights: (FITC-4) 4.4 KDa, (FITC-50) 
50 KDa, and (FITC-580) 580 KDa.  In experiments conducted with these 
molecules the biomolecule solutions were loaded at a concentration of 
70µg/ml.  Samples were taken out at 0, 6, 10, 20, 24, 31, and 45 hours.  The 
second solution was glucose (0.18 KDa), which was chosen because it is a 
key component in cell culture media and necessary for cell nutrition and 
survival.  Glucose was loaded into chamber 1 at a concentration of 100 
mg/ml.  Samples were taken at 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 20, 22, 24 hours.    
 
Figure 6.1: Experimental setup showing the side view (a) and cross sectional view (b) 
of the custom made diffusion chamber. 
Being composed of different layers including the wall of the HUV, the 
loose irregular layer surrounding it, and a Wharton
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is considered anisotropic and non-homogeneous.  Thus the diffusion of 
glucose was calculated through the HUV, as well as the WJ.  Moreover, to 
determine the amount of time necessary for the HUV to become saturated 
with glucose, two different HUV sections were placed in the diffusion chamber 
with two different setups: the first HUV section was immersed in nano pure 
water (unsaturated HUV section), while, in the second setup, the HUV section 
was pre-saturated with 100mg/ml of glucose solution (saturated HUV section) 
for 48 hours on an orbital shaker.   
For all experiments, several 10 µl samples were collected from both 
chambers at each time point, and were replaced by 10 µl of the original 
solution.  Collected samples were diluted to 1 ml using nano pure water.  The 
total volume of samples collected from the chamber was less than 5% of the 
total chamber capacity.  The concentration of different molecules at each time 
point was calculated by measuring the fluorescence or absorbance of the 
sample as illustrated in the following sections.  To calculate the coefficient of 
diffusion, The HUV was considered as a “thin membrane” and a quasi-steady 
state was assumed222.  Equation 6.1 was used to calculate the apparent 
coefficient of diffusion222: 
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Equation 6.1: Quasi-steady transport across a thin membrane 
Using the aforementioned expression it was possible to plot the value 
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Equation 6.2. 
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Equation 6.2: Expression used to determine the apparent diffusion coefficient. 
Where C0 is the initial solute concentration in chamber 1  
  C1 is the measured solute concentration in chamber 1 at time t  
  Am is the cross sectional area of the HUV (0.713cm2) 
  Lm is the thickness of the HUV (0.1 cm) 
V is the volume of each chamber (2.50 ml) 
The permeability of different molecules to the membrane was deduced 
from the apparent coefficient of diffusion using Equation 6.3222. 
m
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Equation 6.3: Relationship between the coefficients of permeability and diffusion. 
6.2.3. Glucose Assay 
Glucose concentrations were computed using an enzymatic method 
that results in an increase in the absorbance of the samples which is 
proportional to the glucose content.  Standards of known increasing glucose 
concentrations were prepared (0, 0.05, 0.1, 0.5, and 1 mg/ml).  Samples and 
standards were assayed in triplicates to account for sampling error.  10 µl of 
sample or standard was added to each well.  Each occupied well was then 
supplemented with 100 µl of glucose assay reagent (Sigma-Aldrich G3293, 
St. Louis, MO, USA).  Blanks were prepared for each sample, in which 100 µl 
of nano pure water replaced the glucose assay reagent.  The plate was 
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incubated on a shaker for 20 minutes allowing the glucose assay reagent to 
react with the samples.  Finally, the absorbance was measured at 340 nm.   
Using the data from the standards a linear relationship was developed 
between the absorbance and the glucose concentration.  The glucose 
concentrations in the assayed samples were determined by linear regression 
analysis of the standard curve. 
The enzymatic method used in this assay results in an increase in the 
final absorbance which is directly proportional to the glucose concentration in 
the sample.  Upon the addition of the glucose assay reagent, glucose is 
phosphorylated by adenosine triphosphate (ATP), in the presence of 
hexokinase, into Glucose-6-Phosphate (G6P) (Equation 6.4).  In a second 
reaction, catalyzed by glucose-6-phosphate dehydrogenase (G6PDH), G6P is 
oxidized to 6-phosphogluconate accompanied by the reduction of 
nicotinamide adenine dinucleotide (NAD) into NADH (Equation 6.5), which 
results in an increase in absorbance signal.  All the components required for 
this reaction to occur are present in the glucose assay reagent, which is 
composed of: 1.5 mM nicotinamide adenine dinucleotide (NAD), 1.0 mM 
adenosine triphosphate (ATP), 1.0 unit/ml of hexokinase, and 1.0 unit/ml of 
glucose-6-phosphate dehydrogenase  
 ADP G6PHexokinase ATP Glucose + →+  
Equation 6.4: Phosphorylation of glucose followed by due to the addition of glucose 
assay reagent. 
NADH  conatephosphoglu-G6PDH NAD  G6P + →+ 6  
Equation 6.5: Reduction of NAD to NADH due to the addition of glucose assay reagent. 
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6.2.4. Measurement of Fluorescence of Dextran Molecules 
For each collected sample triplicates of 100 µl were assayed.  The 
fluorescence of assayed samples was read in a synergy plate reader (Bio-
Tek, Winooski, VT) at an excitation wavelength of 480 nm and emission 
wavelength of 520 nm.  The concentrations were deduced from the degree of 
fluorescence using a pre-generated standard curve. 
6.2.5. Determination of the Partition Coefficient 
The partition coefficient was determined using the same technique 
previously employed to measure glucose partition coefficient of the lower 
layers of the skin223.  Briefly, a 0.75mm thick section of HUV was immersed in 
a solution containing 2mg/ml of glucose in nano pure water.  After 24 hours, 
the glucose concentrations in the HUV and in the solution were measured.  
The partition coefficient was calculated as the ratio of the glucose 
concentration consumed by the HUV to the glucose concentration left in 
solution. 
6.2.6. Statistical analysis 
For each molecular weight 3 HUV sections were tested and results 
were expressed as mean values ± standard deviation.  Statistical analysis to 
compare results among groups was performed using the multivariate analysis 
of variance (ANOVA) method.  A significant difference corresponds to a 
confidence level >95%. 
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6.3. RESULTS 
6.3.1. Apparent Coefficient of Diffusion of Glucose through the 
HUV 
Figure 6.2 shows a plot of the increase in glucose concentration in 
chamber 2 versus time, for both glucose saturated and unsaturated HUV 
sections.  There was an initial increase in the glucose concentration for the 
saturated HUV compared with a zero concentration for the unsaturated HUV 
at time zero.  However, after 10 hours the two curves followed similar paths, 
indicating that the originally unsaturated decellularized HUV tissue became 
saturated with glucose.  Thus, it is recommended to soak the scaffold with 
culturing medium overnight before using it for tissue engineering applications 
Using the linear fit plots for the HUV sections (Figure 6.3-a) and the WJ 
sections (Figure 6.3-b), the average slopes were determined as -0.053 ± 
0.013 for the HUV sections versus -0.063 ± 0.011 for the WJ sections.  The 
resulting average apparent diffusion coefficients were Dapp HUV = 0.21 ± 0.04 
cm2/day versus Dapp WJ= 0.26 ± 0.05 cm2/day, respectively (Figure 6.4). 
 
Figure 6.2: Increase in glucose concentration versus time for glucose saturated and 
un-saturated HUV sections. 
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Figure 6.3: Linear fit plot used to determine the apparent diffusion coefficient of the (a) 
decellularized HUV and (b) Wharton’s Jelly 
 
Figure 6.4: Glucose apparent diffusion coefficient of the HUV and the WJ. 
6.3.2. Glucose Partition Coefficient of the HUV 
Table 6.1 includes a list of the glucose partition coefficients for different 
sections of HUV and WJ having a thickness of 1.0 ± 0.2 mm.  There was no 
significant variability in the glucose partition coefficients of either HUV or WJ 
sections obtained from different umbilical cords since their coefficients of 
variability were 12%, and 3%, respectively.  However, the average glucose 
partition coefficient of the HUV (0.13 ± 0.02) was significantly lower than that 
of the WJ (0.21 ± 0.01).  
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Table 6.1: Glucose partition coefficients for HUV and WJ. 
 Partition Coefficient (φ) 
 HUV WJ 
Section 1 0.13 0.21 
Section 2 0.12 0.20 
Section 3 0.15 0.20 
Average 0.13 0.20 
STDEV 0.02 0.01 
 
6.3.3. Diffusion of Fluorescently Tagged Molecules through the 
HUV 
Large molecules (50 KDa and 580 KDa) did not diffuse through the 
HUV during the time frame of 48 hours.  Figure 6.5 shows the side-by-side 
diffusion chamber  48 hours after being loaded with the fluorescently tagged 
dextran molecules (70 µg/ml) having a molecular weight of 580KDa in 
chamber 1 and nano pure water in chamber 2.  It is clear that none of the 
fluorescent molecules diffused to chamber 2 in which the solution showed no 
fluorescence.  Moreover, there was no decrease in the fluorescence 
concentration with time during the experimental duration of 48 hours.   
Figure 6.6 shows the linear fit plot of the logarithmic of concentrations 
versus time for the diffusion of different molecules through the HUV.  The 
slope for the glucose molecule was -0.053±0.013 while that of the 4.4 KDa 
molecule was -0.013±0.002, resulting in apparent diffusion coefficients of Dapp 
HUV = 0.21 ± 0.04 cm2/day versus Dapp 4.4KDa= 0.05 ± 0.01 cm2/day (Figure 
6.7). 
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Figure 6.5: Diffusion chamber 48 hours after loading fluorescently tagged dextran 
molecules with a molecular weight of 580 KDa. 
 
 
Figure 6.6: Linear fit plot used to determine the apparent diffusion coefficient of 
molecules with different molecular weights through the HUV. 
 
 
Figure 6.7: Apparent diffusion coefficient of molecules with different molecular weights 
through the HUV. 
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6.4. DISCUSSIONS 
Although the average apparent diffusion coefficient of glucose through 
the WJ was slightly higher than that through the full HUV section, there was 
no statistical difference between the two values.  The tested section of HUV 
had a total thickness of 1.0 ± 0.2 mm.  Knowing that the wall of the HUV only 
composes 0.54 ± 0.02 mm219 of the total thickness, we could deduce that the 
tested section of HUV had almost 45% of WJ matrix in it (Figure 6.8).  The 
wall of the HUV, in turn, is composed of three sub-layers: intima (14%), media 
(59%) and adventitia (27%)219.  Considering the variability in the thicknesses 
of the different layers composing the HUV, it would be more meaningful to 
compare the permeability of the membrane to glucose rather than the 
coefficient of diffusion through the HUV224.  Since the flow of nutrients is 
passing through the two main stratified layers of the HUV, then the total 
coefficient of permeability (PHUV) is limited by the individual coefficients of 
permeability of the WJ (PWJ) and the HUV wall (PHUV wall) layers.   
HUV wallPPP WJHUV
111
+=  
Equation 6.6: The average permeability coefficient across the full HUV as a function of 
the permeability coefficients of individual layers. 
Using the above relation, and normalizing the coefficients of 
permeability by the individual layer thickness, the resulting glucose coefficient 
of permeability through the WJ was PWJ = 3.0x10-5 ± 5.4x10-6 cm/sec 
significantly larger than that of the HUV wall PHUV wall = 2.2x10-5 ± 5.0x10-6 
cm/sec (Figure 6.9).  This was expected since the wall of the HUV includes 
the media layer that is composed of packed smooth muscle fibers and 
densely interwoven collagen fibers219 compared to the loose architecture of 
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the fibers of the WJ (Figure 6.10).  This observation was also reflected in the 
results of glucose partition coefficient that was significantly lower for the HUV 
(0.13 ± 0.02) than for the WJ (0.21 ± 0.01).  
 
Figure 6.8: Schematic cross-section showing the main two layers composing the HUV. 
 
Figure 6.9: The permeability of different layers of the HUV to glucose. 
The resulting permeability coefficients of the HUV to molecules with 
different molecular weights were documented in Table 6.2.  Although large 
molecular weight dextrans (> 50 KDa) did not diffuse through the HUV, it 
could not be concluded that proteins having a molecular weight larger than 50 
KDa would not permeate through the membrane.  Two molecules having the 
same molecular weight might have significantly different geometries.  For 
instance, bovine serum albumin has a molecular weight of 65 KDa but a 
molecular radius R = 3.5 nm224 significantly lower than FITC-50 with an R = 
4.9 nm Table 6.2.  Thus, it was necessary to compare the permeability of the 
HUV using the molecular radius, or Stoke’s radius, rather than the molecular 
0.75 mm 
WJ 
HUVwa
0.41 mm Ab-luminal side 
87 
weight.  Therefore, large proteins, such as immunoglobulin G antibodies 
(MW=140 KDa)224, having a molecular radius of 5.0 nm224 larger than 4.9 nm 
would not diffuse through the wall of the HUV. 
 
Figure 6.10: Longitudinal histological section of the decellularized inverted HUV 
showing fiber density in the different layers. Tunica Media (M), Tunica Adventitia (A), 
and Wharton’s Jelly (WJ). 
Table 6.2: Molecular weights (MW), Radii of gyration (Stokes radii, R) 225-227, and their 
coefficients of permeability (P) through the HUV. 
Tracer MW (KDa) R (nm) P (cm/sec) 
Glucose 0.18 0.4 2.5x10-5 ± 5.0x10-6 
FITC-4 4.4 1.3 6.4x10-6 ± 9.0x10-7 
FITC-50 50 4.9 0 
FITC-150 150 8.2 0 
FITC-580 580 14.8 0 
The apparent coefficient of diffusion through the HUV decreased 
exponentially with the increase in the molecular weight.  However, an 
inversely proportional relationship was revealed when the coefficient of 
permeability was plotted against the molecular radius (Figure 6.11).  Thus, 
using the resulting relation it is possible to predict the coefficient of 
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permeability of dextrans with different molecular weights through the HUV.  
However, dextran is known to be neutral.  Thus, the proposed relation cannot 
be used to predict the diffusivity of proteins with different chemical properties, 
such as surface charge, that might demonstrate a strong affinity for the HUV.   
One limitation of the current work is the dependency of all the 
documented results on the method employed to decellularize the HUV.  
Different decellularization techniques result in scaffolds with altered 
architectures, and thus the partition, diffusion, and permeability coefficient 
would vary significantly.  For similar reasons, the presented values are not 
proper to analyze the cellular HUV.   
 
Figure 6.11: A plot showing the permeability coefficient of the HUV versus the 
molecular radius (Stoke’s radius) of the diffusing molecule.  The coefficient of 
permeability demonstrates an inversely proportional relation with the molecular radius. 
6.5. CONCLUSIONS 
It was determined that glucose permeability through the HUV wall was 
significantly lower than that through the WJ.  It took the membrane almost 10 
hours to get saturated with glucose.  Thus to enhance glucose transport 
through the HUV on the onset of experimental setup, it is recommended to 
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soak the biological scaffold overnight with media before using it for tissue 
engineering applications which involve seeding cells at the interior void space 
of the HUV that lacks direct access to the cell culture media.  Thus the cells 
initially seeded in the central cylindrical space of the HUV depend solely on 
diffusion to acquire glucose and other necessary metabolites for their survival 
and proliferation.  If the cellular glucose consumption rate is known it would be 
possible to calculate the maximum number of cells that are able to reside in 
the central space of the HUV and still be sufficiently nourished.  
The coefficient of permeability of glucose was almost an order of 
magnitude higher than that of FITC-Dextran 4.4 KDa.  An inversely 
proportional relation was developed between the molecular radius and the 
permeability of dextran molecules through the HUV.  However, this relation 
could be used to predict the coefficient of permeability of proteins that do not 
possess a strong net surface charge or a strong affinity for the HUV.  High 
molecular weight FITC-Dextran molecules did not diffuse through the HUV, 
limiting the molecular radius of proteins that could permeate through the 
biological scaffold to less than 4.9 nm.   
In Chapter 7 the cellular glucose consumption is computed and the 
maximum number of cells that could be efficiently seeded into the HUV is 
calculated.  
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CHAPTER 7 
OPTIMIZING SEEDING DENSITY FOR A TISSUE ENGINEERED TENDONS 
USING THE HUMAN UMBILICAL VEIN 
7.1. INTRODUCTION 
The main three components of functional tissue engineering are cells, 
a biocompatible scaffold to house the cells and give the construct initial 
mechanical integrity, and a bioreactor which provides the appropriate 
biochemical and biomechanical signals to regulate cell differentiation and 
tissue assembly89,93-95.  The initial seeding density is a critical variable in the 
attainment of a functional engineered tissue since cells are responsible for 
tissue deposition and extracellular matrix (ECM) remodeling.  A large number 
of cells is required on the scaffold to achieve successful ECM deposition in 
vitro142,143.  Moreover, uniform cell seeding throughout the scaffold is required 
to obtain homogeneous tissue formation throughout the scaffold, including the 
central part92.   
To our knowledge, only one study has been performed on the effect of 
seeding density on the morphometric properties of engineered tendons in-
vitro.  Collagen gels were seeded with rabbit MSCs at three different densities 
(1, 4, and 8 million cells/ml) and tensioned longitudinally228.  Higher seeding 
densities resulted in more aligned and elongated cell nuclei 72 hours after 
seeding.  No further investigation was conducted for cultures beyond 72 hours 
and no mechanical analysis was performed on the constructs.  Extending the 
above study to include longer culture periods and mechanical analyses on 
constructs would provide valuable insight towards engineering a functional 
tendon model. 
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In a previous study the potential of the HUV, seeded with 1 million 
cells/ml and cyclically stretched for durations up to 2 weeks, to act as a tissue 
engineered tendon was assessed.  There was a need to optimize potentially 
critical culture parameters such as seeding density, loading regimes, and 
stretching durations.  Thus, in this study at attempt at optimizing seeding 
densities is made.  Since a low seeding density of 1 million cells/ml was 
already considered, in the current study the effect of 2 additional seeding 
densities on the morphometric and mechanical properties of the tissue 
engineered tendon would be investigated: Medium Seeding Density (MSD = 5 
million cells/ml) and High Seeding Density (HSD = 10 million cells/ml).  
Moreover, the cellular glucose consumption would be measured,.  Knowing 
glucose diffusion coefficient through the HUV, the limiting seeding density 
inside the HUV would be computed. 
7.2. MATERIALS AND METHODS 
7.2.1. Preparation of the HUV 
Refer to section 4.2.1 and 4.2.2. 
7.2.2. Cell Source 
Refer to section 4.2.3. 
7.2.3. Experimental Setup 
Refer to section 4.2.4 and 5.2.4. 
Two groups were considered: Static samples were seeded controls 
cultured in the bioreactor without any mechanical stimulation; and dynamic 
cultures were seeded constructs cultured in the bioreactor and subjected to 1 
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hour of cyclic stretching per day at 2% strain and a frequency of 0.0167 Hz.  
Constructs were cultured for durations of 1 and 2 weeks.  At the end of each 
culture duration, constructs were tested for glucose consumption, cell density 
by quantifying DNA content, morphology using histology, and mechanical 
properties by stretching to failure. 
7.2.4. Calculation of Glucose Consumption  
Two different methods were employed to calculate the glucose 
consumption per cell:  2-dimensional (2D) setup in 6-well plates, and a 3-
dimentional (3D) setup using the HUV.   
7.2.4.1. 2D Setups 
For 2D setups cells were mixed with type I collagen gel and then 
suspended on plasma treated 6-well plates (BD Biosciences, San Jose, CA).  
The final concentration of collagen gel was 2 mg/ml.  The collagen mix was 
allowed to polymerize at 37°C for 1 hour after which the cellular hydrogel was 
covered with 5 ml of standard media.  The well plates were placed in an 
incubator at 37°C and 5% C02.  Three different seeding densities were 
employed to investigate if the initial seeding density has an effect on the 
glucose consumption per cell: low seeding density of 5,000 cells/cm2, medium 
seeding density of 20,000 cells/cm2, and high seeding density of 50,000 
cells/cm2. Triplicate wells were prepared for each seeding density.  After 24 
hours of seeding the samples were nourished with fresh standard media.  0.5 
ml samples were collected after 4 hours of incubation and tested for glucose 
content.  Fresh media in a blank well plate was used as a control.  The cell 
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number per well was quantified to permit evaluations of glucose consumption 
per cell. 
7.2.4.2. 3D setups 
In this setup glucose consumption was measured for seeded HUVs 
that were cultured for 1 week in the MSTE, as described previously.  
Constructs cultured in the MSTE were nourished with fresh media at day 6.  A 
1 ml centrifuge tube was filled with fresh media and placed in the incubator as 
a control sample.  At day 7, 0.5 ml of media was collected from the MSTE and 
tested for glucose content.  The constructs were also tested for DNA content.  
This allowed us to compute the glucose consumption per construct as well as 
the glucose consumption per cell. 
7.2.4.3. Glucose Assay 
Samples and controls stored in centrifuge tubes were tested for 
glucose content using an enzymatic method as follows.  In a transparent 96-
well plate, 10 µl of sample/control were pipetted into predetermined wells.  
Each occupied well was then supplemented with 100 µl of glucose assay 
reagent (Sigma-Aldrich G3293, St. Louis, MO, USA).  Blanks were prepared 
for each sample/control, in which 100 µl of nano pure water replaced the 
glucose assay reagent.  The addition of the glucose assay reagent results in a 
series of reactions which lead to the reduction of nicotinamide adenine 
dinucleotide (NAD) into NADH.  This reduction, in turn, causes an increase in 
the absorbance signal, which is proportional to the sample glucose content.  
The plate was incubated on a shaker for 20 minutes allowing the glucose 
assay reagent to react with the glucose present in the samples, and the 
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absorbance was measured at 340 nm read using a Synergy HT plate reader 
(Bio-Tek, Winooski, VT).  A plot was generated using the absorbance signals 
from standards with known glucose concentrations ranging between 0 and 1 
mg/ml.  The glucose concentrations in the assayed samples/controls were 
deducted from the linear regression analysis of the standard curve. 
The glucose consumption was calculated as the difference between 
the glucose content of the control and that of the sample.  Glucose 
consumption results were normalized by the number of cells in each sample. 
7.2.5. Quantifying Cell Number 
To quantify the cell number in each setup a PicoGreen DNA 
quantification kit (Invitrogen) was used.  Cell number was quantified in two 
different setups: 2D-setups for cellular collagen hydrogels in 6-well plates, and 
3D-setups for seeded HUV constructs.  Different methods were used to 
prepare the two setups for the DNA assay. 
7.2.5.1. 2D Setups 
The media covering the well plates was discarded and cells were 
scraped with a cell scraper and dissolved in 1 ml of nano pure water.  The 
cellular mix was sonicated in ice for 1 minute and then subjected to three 
freeze/thaw cycles to help cell lyses and release of the DNA into the solution.  
7.2.5.2. 3D setups 
To prepare the HUV for cell number analysis small 0.5 cm diameter 
ringlets were cut from three different locations (2 from each end and 1 from 
the middle section) to get an average representative number.  Section were 
then dissected into smaller pieces ≤ 2mm2, and incubated with 1mm of 
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collagenase type I (MP Biomedicals, Solon, OH) for 5 hours at 37°C to help 
release the cells by digesting the extracellular matrix of the HUV.  Then the 
solution was treated in a method similar to the 2D-setups, including sonication 
for 1 minute in ice followed by three freeze/thaw cycles. 
7.2.5.3. DNA Assay 
Refer to section 4.2.5. 
7.2.6. Histology 
Refer to section 4.2.6.  
7.2.7. Mechanical Testing 
Refer to section 4.3.3. 
7.2.8. Statistical analysis 
Refer to section 4.2.8. 
7.3. RESULTS 
7.3.1. Cell Proliferation 
Table 7.1 includes cellularity of constructs and Figure 7.1 shows plots 
of cellular proliferation for the MSC and HSD 1 and 2 weeks post culture.  A 
total volume of 0.6 ml of cellular collagen mix was originally inserted in the 
HUV.  Thus, with a seeding density of 5 million cells/ml, the total number of 
cells originally inserted in the HUV was 3 million cells.  Similarly, 6 million cells 
were inserted in the HUV for the high seeding density.   
A significant increase in cell number was measured for the MSD 
(Figure 7.1-a) after 1 week of culture for both static and dynamic conditions, 
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however, there was no significant difference among the cellularity of the two 
culturing techniques (stretched versus unstretched).  The cellularity of the 
HUV (Table 7.1) increased from 3 million to 7.8 ± 2.0 million cells for static 
controls and to 9.2 ± 1.4 million cells for stretched constructs.  No additional 
increase in cell number was recorded for the construct 2 weeks post culture. 
Contrarily to the above results, no significant increase in cell number 
was measured for the HSD for either culturing regimes at any time duration 
(Figure 7.1-b).   
Table 7.1: Cellularity of constructs 1 and 2 weeks post culture. 
 5 million cells/ml 10 million cells/ml 
 Static Dynamic Static Dynamic 
Original  3.00 6.00 
1 Week 7.8 ± 2.0 9.2 ± 1.4 5.9 ± 1.5 5.0 ± 0.7 
2 Weeks 6.3 ± 0.8 1.1 ± 0.4 6.3 ± 0.8 5.5 ± 1.1 
 
 
Figure 7.1:  Plots of cell number (in million) per construct versus culturing duration for 
an initial seeding density of (a) 5 million cells/ml and (b) 10 million cells/ml. 
7.3.2. Histology 
Figure 7.2 shows the morphology of the HUV seeded with 5 million 
cells/ml after 1 week of culture.  The HUV membrane seemed to preserve its 
original dissection thickness for both untensioned (Figure 7.2-a) and cyclically 
tensioned constructs (Figure 7.2-b).   
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Figure 7.2: Histologic cross sections of the HUV seeded with 5 million cells/ml after 1 
week of culture (a) static, (b) dynamic, (c) static at a high magnification of 10X, and (d) 
dynamic at a high magnification of 10X. 
For both culturing conditions cells were able to proliferate and migrate 
into the wall of the HUV (Figure 7.2-c and Figure 7.2-d).  It is clear that the 
scaffolds were occupied with numerous cells, some of which had reached the 
outer wall of the HUV in the case of stretched constructs.  One significant 
observation is that the extracellular matrix of unstimulated constructs 
appeared to be degrading (Figure 7.2-c), since fewer fibers surround the cells 
compared to the extracellular matrix of the tensioned constructs (Figure 7.2-
d).  This observation was more obvious after two weeks of culture, where the 
wall of the HUV looked significantly thinner for both culturing conditions 
(Figure 7.3-a and Figure 7.3-b) compared to the scaffolds after 1 week of 
culture (Figure 7.2-a and in Figure 7.2-b).  Fibers were clearly short and 
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disconnected (Figure 7.3-c) unlike the connected mesh-like morphology of the 
original decellularized HUV (Figure 7.3-f).  Moreover, cells in the tensioned 
reactors had an irregular shape (Figure 7.3-d) which indicated to be lysed cell 
bodies at a magnification of 40X (Figure 7.3-e).  
 
Figure 7.3: Histologic cross sections of the HUV seeded with 5 million cells/ml after 2 
week of culture (a) static, (b) dynamic, (c) static with high magnification of 20X, (d) 
dynamic at a high magnification of 20X.  (e) Close up at 40X showing lysed cell bodies 
after two weeks of stretching.  (f) Decellularized HUV. 
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Figure 7.4: Histologic cross sections of the HUV seeded with 10 million cells/ml after 1 
week of culture (a) static, (b) dynamic.  HUV 2 weeks post culture (c) unstretched, and 
(d) stretched, (e) unstretched at a high magnification of 10X, and (f) stretched at a high 
magnification of 10X. 
Similar results were observed for the HSD where the degradation of the 
matrix was more obvious at earlier culture durations.  In Figure 7.4-a and 
Figure 7.4-b numerous cells appeared to be filling the central portion of the 
HUV for static and dynamic constructs, respectively.  However, compared to 
the histological sections of MSD, the wall of the HUV looked thinner and the 
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matrix looked significantly degraded, especially for the unstretched samples.  
The thinning of the membrane persists after 2 weeks of culture (Figure 7.4-c 
and Figure 7.4-d).  Fewer cells are visible in and around the HUV matrix 
(Figure 7.3-e and Figure 7.3-f).  
7.3.3. Mechanical Properties 
Figure 7.5 includes the results of assessed mechanical properties for 
both seeding densities.  For the MSD, an improvement in mechanical 
properties was observed after the first week of culture.  A statistically 
significant increase in the ultimate tensile stress values was recorded for 
tensioned samples (4100±500 KPa) compared to 1000±300 KPa for 
untensioned constructs and 900±100 KPa for decellularized HUVs.  No 
additional increase in tensile strength was measured after 2 weeks of culture 
(Figure 7.5-a). 
A similar trend was observed for the modulus of elasticity (E) values.  
Decellularized scaffolds had a modulus of elasticity E = 3.3±0.6 MPa.  After 1 
week of culture E almost doubled for static controls (E = 6.2±1.8 MPa) and 
quadrupled for cyclically stretched constructs (E = 12.6±4.4 MPa).  No 
additional increase in the modulus was measured after 2 weeks of culture 
(Figure 7.5-b). 
For the HSD, no significant increase in the ultimate tensile stress was 
observed for any culturing condition at either culturing points (Figure 7.5-c).  
However, a statistically increased trend was observed for the modulus of 
elasticity for both static and dynamic samples where E increased from 3.3±0.6 
MPa to 10.4±1.1 MPa for unstretched constructs and to 12.2±3.1 MPa for 
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stretched construct 2 weeks post culture (Figure 7.5-d).  No significant 
difference was observed among the 2 groups at any culturing duration. 
 
Figure 7.5: Mechanical properties of the seeded HUV for different culture periods 
including tensile strength (a) and modulus of elasticity (b) for the medium seeding 
density, and tensile strength (c) and modulus of elasticity (d) for the high seeding 
density. 
7.3.4. Glucose Consumption 
For 2-D setups, the glucose consumption significantly depended on the 
cell number where an inversely proportional relationship was observed among 
the two variables (Figure 7.6).  The glucose consumption varied between 0.6 
ng/cell for high seeding densities of 50,000 cells/cm2 and 7.0 ng/cell for low 
seeding densities of 5,000 cells/cm2.  When the glucose consumption was 
plotted against the inverse of the cell number, a linear regression plot was 
generated (Figure 7.8) with an R2 value of 0.97.   
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Figure 7.6: (a) inversely proportional relationship between glucose consumption and 
cell number and (b) linear regression between cellular glucose consumption and the 
inverse of the number of cells. 
Similar trends were obtained for 3D setups of HUVs cultured in the 
bioreactor (Figure 7.7).  Even through both cultures resulted in a decreasing 
trend, however, glucose consumption per cell decreased linearly with the 
increase in cell number for 3D setups compared to an inversely proportional 
relationship for 2D setups 
 
Figure 7.7: Linear relationship between glucose consumption per cell and cell number 
for 3D setups in the bioreactor. 
7.4. DISCUSSIONS 
The decellularized HUV has been previously seeded with 1 million 
cells/ml (Low Seeding Density: LSD) and mechanically stimulated for 1 
hour/day at a frequency of 0.0167 Hz and 2% strain.  After 2 weeks of culture, 
103 
the constructs had a 20 fold increase in cell number and a 3 fold increase in 
ultimate tensile strength values.  Histologically, fibers aligned parallel to the 
direction of stretching and cells populated the scaffold almost migrating 75% 
into the thickness of the HUV.  In an attempt to better understand the effect of 
the original seeding density on the final morphologic and material properties 
of the tissue engineered constructs, two additional seeding densities were 
further investigated: Medium Seeding Density (MSD = 5 million cells/ml) and 
high seeding density (HSD = 10 million cells/ml).   
For MSD constructs, a statistically significant increase in cell number 
was measured after 1 week of culture for both, tensioned and untensioned 
constructs.  However, no additional increase in cell number was recorded 2 
weeks post culture.  Moreover, HSD constructs did not show any significant 
increase in cell number during the 2 weeks of culture.  There results were in 
agreement with histologic slides.  Cross sections for the MSD 1 week post 
culture revealed numerous cells invading the ECM of the scaffold reaching the 
outer wall of the HUV for both, stimulated and unstimulated constructs (Figure 
7.2).  However, after the end of the second week of culture the wall of the 
HUV became thinner, the ECM fibers appeared to be degraded, and lysed cell 
bodies were present in significant numbers for both culturing conditions 
(Figure 7.3).  Similar observations were noted for the high seeding density 
after only 1 week of culture. 
Numerous lysed cell bodies are noted in Figure 7.2-d for stretched 
constructs after 2 weeks of culture.  Moreover, the ECM appeared to be 
significantly different from the original matrix of the decellularized HUV (Figure 
7.2-f) denoting extensive ECM remodeling by proliferating cells.   
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Mechanical testing revealed an increase in the mechanical properties 
(ultimate tensile strength and modulus of elasticity) for stretched MSD 
constructs only 1 week post culture.  No further increase in the mechanical 
properties was measure after 2 weeks of culture.  For HSD constructs the lack 
of cell proliferation, thinning of the HUV wall, and evident degradation of the 
ECM all contributed to the lack of improvement in the mechanical properties 
of the constructs. 
 
Figure 7.8: (a) Comparison, among three different seeding densities, of (a) Proliferation 
rates, and (b) Tensile strength. 
Figure 7.8-a shows the fold increase in cell number within the HUV for 
all three seeding densities: Low Seeding Density (LSD = 1 million cells/ml), 
Medium Seeding Density (MSD = 5 million cells/ml), and High Seeding 
Density (HSD = 10 million cells/ml).  Figure 7.8-b includes the corresponding 
increase in ultimate tensile stress values.  For the MSD, the cellularity within 
the constructs increased more than 2 fold 1 week post culture (Figure 7.8-a).  
These results were consistent with proliferation rates within HUVs seeded 
with the LSD.  With similar proliferation rates, MSD stimulated HUVs had an 
ultimate stress value of 4.1 ±0.5 MPa, almost 4 fold higher than LSD stretched 
constructs (Figure 7.8-b).  However, proliferation ceased after 2 weeks of 
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culture, and no increase in the ultimate tensile strength was measured for 
MSD constructs.  LSD stimulated construct, on the other hand, showed an 
additional 20 fold increase in proliferation rates, accompanied by a 1 fold 
increase in the ultimate tensile stress value after 2 weeks of culture (Figure 
7.8).  This is in agreement with other studies in which lower seeding densities 
using MSCs resulted higher proliferation rates229 
It is possible that not enough nutrients were available for the cells to 
proliferate and survive at the MSD and HSD.  Moreover, cells could have 
been attempting to remodel the ECM by secreting metalloproteinases 
(MMPs).  However, the rate of ECM deposition was not balanced by the rate 
of MMP secretion.  When cells remodel the ECM, they also deposit new 
matrix that could potentially decrease the effective porosity of the scaffold, 
and in turn decrease the flow of nutrients through the membrane.  These facts 
would result in an increase in mass transport limitations which could be 
causing the cells to lyse.   
Another possible explanation for the lack of proliferation is due to the 
entrapment of the cell lysates in the scaffold rather than being washed out of 
the matrix.  Since cells are originally seeded in the central portion of the HUV 
and the media is being supplied around the outer wall of the scaffold that has 
a poor porous network, it is possible that cell lysates concentrated with time in 
the scaffold which could affect the condition of the healthy cells.  Moreover, at 
MSD and HSD cells become metabolically more active which leads to an 
increase in metabolic byproducts such as production of lactic acid.  The 
accumulation of lactic acid in the HUV causes a PH drop accompanied by an 
acidic environment that would become toxic to the remaining viable cells and 
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might be the cause of ECM degradation.  This could explain why the media in 
the system was turning orange almost 1 week after culture for MSD and HSD.  
The documented results indicate that cells were not able to survive at 
an original seeding concentration equal to or higher than 5 million cells/ml.  As 
a result, it is recommended to optimize the original seeding density to a value 
between 1 and 5 million cells/ml or modify the HUV to improve the transport of 
nutrients. 
Cellular glucose consumption significantly depended on the cell 
number.  For both 2D and 3D setups; the higher the cell number the lower the 
glucose cellular consumption.  MSCs are affected by the availability of 
glucose in cell culture, where high glucose concentrations induced replicative 
senescence and apoptosis230.  Cells cultured in the 3D matrix of the HUV 
consumed almost 20 fold the amount of glucose as opposed to cells cultured 
in 2D well plates.  For example, 1.8 million cells cultured in the HUV 
consumed 10.5 ng/cell/day of glucose, while, 1.4 million cells cultured in the 
2D well plate consumed only 0.6 ng/cell/day of glucose.  The differences in 
the results between the two setups were expected since 2D cultures result in 
significantly different cell phenotype compared to 3D cultures231.  Cells in a 3D 
environment develop different morphologies, cellular adhesions, and signaling 
pathways compared to cells in conventional 2D tissue cultures232-234.  Cellular 
biological activities are significantly enhanced232,235, and cell migratory 
velocities234 and proliferation rates235 increase in 3D cultures compared to 2D 
cultures.  Since the metabolic activity of cells is influenced by cell-cell 
interactions, and since the 2D well plate has a significantly smaller space for 
cells to grow than the HUV, it is more relevant to compare the cellular glucose 
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consumption per cellular space available.  Thus, the cellular glucose 
consumption for MSCs seeded in the 2D setup is comparable to that seeded 
in the HUV at low seeding densities (7.0 ng/cell/day compared to 10.5 
ng/cell/day, respectively).  
In order to compute a limiting initial seeding density in the HUV above 
which no glucose would be available to cellular nutrition Fick’s first law of 
diffusion (Equation 7.1) could be applied.  Using Equation 7.1 it is possible to 
compute the flux of glucose, by diffusion, from the media surrounding the 
outer wall of the HUV into the full thickness of the decellularized scaffold. 
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Equation 7.1: Fick’s first law of diffusion. 
Where: J is the flux (mg/cm2/day). 
Dapp is the apparent glucose diffusion coefficient across the 
membrane.  Dapp was previously measured to be 0.21 ± 0.04 
cm2/day. 
dCm is the change in the glucose concentration across the HUV 
membrane. 
Co is the concentration of glucose outside the HUV that is 
available in the culture media = 1mg/ml. 
Ci is the concentration of glucose on the internal surface of the 
HUV. 
Lm is the thickness of the HUV = 0.1 cm. 
Assuming that all the available glucose that diffuses across the HUV 
membrane gets consumed by cells (Ci = 0 mg/ml), the resulting flux would be: 
J = 2.16 mg/cm2/day.  Knowing the circumferential area of the HUV = 8.5 cm2, 
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the available glucose for cellular consumption inside the wall of the HUV was 
18 mg/day.  The resulting cellular glucose consumption inside the HUV was 
dependent on the cellularity of the construct, as stated earlier.  Table 7.2 
shows the resulting limiting seeding densities using the cellular glucose 
consumptions for HUVs with different cellularities. 
Table 7.2: Limiting number of cells inside the HUV. 
HUV Cellularity 
(millions) 
Glucose consumption 
(ng/cell/day) 
Calculated Limiting Cell Number 
(millions) 
39.5  1.8  10.4 
11.1  7.8  2.4 
1.8  10.5  1.8 
It is important to note that the method employed to calculate the 
number of cells was PicoGreen DNA assay.  This method measures the DNA 
concentration in the tissue, which is converted to cell number knowing the 
cellular DNA concentration.  Thus, not all the reported cellularities represent 
viable cells.  Therefore, the glucose consumption rate might be 
underestimated.  One more limitation is that glucose consumption and DNA 
assay were performed on the HUVs after 6 days in culture.  As a result, not all 
the cells are present in the central portion of the HUV, some cells had already 
migrated and populated the scaffold.  Since we are attempting to calculate a 
limiting seeding density, then the cellular glucose consumption that results in 
a limiting cell number comparable to the cellularity of the HUV would be 
considered.  According to the values in Table 7.2 the limiting number of cells 
in the HUV is 1.8 million cells which corresponds to a seeding density of 3 
million cells/ml.  This value is in agreement with the above results that 
indicated that the optimal seeding density is between 1 and 5 million cells/ml.  
It is important to note that when the HUVs are mechanically stimulated, 
nutrients do not only diffuse through the scaffold, but there is also a 
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convective flow due to the effect of stretching.  This convective force 
potentially enhances the transport of nutrients through the wall of the HUV.  
Thus, the limiting seeding density of 3 million cells/ml corresponds to non-
stimulated controls.  Coupling the constructs with stretching would increase 
the allowable seeding density, with 3 million cells/ml being a minimum 
number. 
7.5. CONCLUSIONS 
Higher seeding densities resulted in an initial increase in proliferation 
rates and a modest improvement in mechanical properties.  However, 
proliferation ceased after the second week of culture, and constructs had 
poorer mechanical properties with seemingly thinner HUV walls and degraded 
ECM.  Histologic images revealed lysed cell bodies 2 weeks post culture.  It 
appears that at high seeding densities not enough glucose diffused through 
the HUV to support cell survival and proliferation.  The optimal seeding 
density was found to be less than 5 million cells/ml.  A decreasing linear 
relationship was recorded between the number of cells in the HUV and the 
cellular glucose consumption with values ranging between 1.8 ng/cell/day and 
10.5 ng/cell/day.  The limiting seeding density was calculated based on 
glucose consumption rates to be 3 million cells/ml for unstretched samples.  
This number increases for mechanically stimulated sample due to the effect of 
convective flow.  Finally, the numbers reported in this study are highly 
dependent on the current design and experimental procedures employed.  
Thus, varying any factors, such as the decellularization procedure, thickness 
of the HUV, stimulation scenarios, or seeding protocol, would significantly 
affect the documented results. 
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CONCLUSIONS AND RECOMMENDATIONS 
7.6. CONCLUSIONS 
The Human Umbilical Vein (HUV) was presented in this research study 
as a potential biological scaffold for musculoskeletal tissue engineering in 
general, and tendon tissue engineering in particular.  The HUV, seeded with 
Mesenchymal Stem Cells (MSCs), supported cell integration, proliferation and 
migration to the existing 3 dimensional matrix of the scaffold.  The seeded 
constructs possessed higher mechanical properties than the original 
decellularized HUV.  Mechanically stimulating constructs with 2% strain for 
one hour per day increased the proliferation rate of MSCs and gave the 
construct a tendon like appearance.  Histological images showed extracellular 
matrix fibers and cell nuclei aligned parallel to the direction of stretching 
mimicking the morphology of native tendons.  Moreover, mechanostimulation 
resulted in significantly stronger and stiffer constructs compared to un-
tensioned samples.   
To characterize the HUV as a biological scaffold for tissue engineering, 
mass transport of nutrients through the HUV was investigated.  It was 
determined that glucose permeability through the HUV wall was significantly 
lower than that through the Wharton’s Jelly.  It took the membrane almost 10 
hours to get saturated with glucose.  Thus to enhance glucose transport 
through the HUV on the onset of experimental setup, it is recommended to 
soak the biological scaffold overnight with media before using it for tissue 
engineering applications which involve seeding cells at the interior void space 
of the HUV that lacks direct access to the cell culture media.  Cells initially 
seeded in the central cylindrical space of the HUV depend solely on diffusion 
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rates to acquire glucose and other necessary metabolites for their survival 
and proliferation.   
The coefficient of permeability of glucose was almost an order of 
magnitude higher than that of FITC-Dextran 4.4 KDa.  An inversely 
proportional relation was developed between the molecular radius and the 
permeability of dextran molecules through the HUV.  However, this relation 
could be used to predict the coefficient of permeability of proteins that do not 
possess a strong net surface charge or a strong affinity for the HUV.  High 
molecular weight FITC-Dextran molecules did not diffuse through the HUV, 
limiting the molecular radius of proteins that could permeate through the 
biological scaffold to less than 4.9 nm.   
When higher seeding densities, of 5 million cells/ml, and 10 million 
cells/ml, were attempted, the ECM of the HUV significantly degraded, 
mechanical properties of the constructs did not show any improvement, and 
cell bodies lysed after 2 weeks of culture, for both tensioned and un-tensioned 
constructs.  These results indicated that cells were not able to survive at 
original seeding concentration higher than 5 million cells/ml.  A decreasing 
linear relationship was recorded between the number of cells in the HUV and 
the cellular glucose consumption with values ranging between 1.8 ng/cell/day 
and 10.5 ng/cell/day.  The limiting seeding density for unstimulated samples 
was calculated based on glucose consumption rates to be 3 million cells/ml.  
This value increases for mechanically stimulated constructs due to the effect 
of convective flow associated with stretching. 
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7.7. RECOMMENDATIONS 
7.7.1. Investigating the Effect of Alternative Stretching Regimes 
on the Seeded HUVs 
In the current study the seeded HUVs were only stretched for 1 
hour/day in the MSTE at 2% strain and a frequency of 0.0167Hz.  In other 
studies constructs were stretched up to 8 hours203 and 24 hours180 per day at 
strains ranging between 2.4% and 12%129,131,180,203.  It has been previously 
reported that mechanical properties of collagenous substrates strongly 
depended on the form, magnitude, and duration of stress applied, and that 
cyclic stresses work more effectively than static stresses in the biological 
system156,183.  Thus it is recommended to investigate the effect of different 
stretching durations, intensities, and frequencies on the morphometric and 
mechanical properties of the tissue engineered tendon in order to optimize 
mechanical stimulation variables. 
7.7.2. Investigating the Potential of Facilitating Mass Transport 
through the HUV 
The current HUV has a very tortuous network of pores that limits the 
molecular radius of proteins that could permeate through the biological 
scaffold to less than 4.9 nm.  This limitation will increase as cells migrate into 
the HUV to remodel the existing matrix and deposit new ECM.  Thus, it is 
recommended to investigate techniques that would facilitate mass transport of 
nutrients and biomolecules through the scaffold.  One option would be to poke 
micro-holes into the HUV after seeding it with MSCs.  Another possibility 
would be to perfuse media through the central portion of the HUV by 
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incorporating small channels in the steel adapters that hold the ends of the 
scaffold. 
7.7.3. Investigating other Decellularization Options 
The material properties of the HUV depend strongly on the 
decellularization technique used.  In the current study the surfactant SDS was 
the primary decellularization product.  It is recommended to investigate the 
effect of other decellularizing agents, such as ethanol, Triton-X, or tributyl 
phosphate, on glucose and metabolite coefficients of diffusivity through the 
HUV.  
7.7.4. Developing a Finite Element Model 
A finite element model of the HUV would be very beneficial as a critical 
tool to help simulate and understand the effects of nutrients’ diffusion through 
the scaffold on cell migration, proliferation and new extracellular matrix 
deposition. 
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